PT J
AU Zhang, Y
   Yu, YJ
   Li, X
   Meguro, S
   Hayashi, S
   Katashima, M
   Yasumasu, T
   Wang, JZ
   Li, KJ
AF Zhang, Ying
   Yu, Yingjie
   Li, Xu
   Meguro, Shinichi
   Hayashi, Satoshi
   Katashima, Mitsuhiro
   Yasumasu, Takeshi
   Wang, Jingzhong
   Li, Keji
TI Effects of catechin-enriched green tea beverage on visceral fat loss in adults with a high proportion of visceral fat: A double-blind, placebo-controlled, randomized trial
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Body weight; Body fat mass; Catechins; Green tea; Visceral fat; Functional beverage
ID diet-induced obesity; abdominal fat; body-fat; extract; rich; supplementation; consumption; reduction; oxidation; humans
AB The effects of catechin-enriched green tea on Chinese adults with a high proportion of abdominal visceral fat were evaluated. Subjects (118) were randomly assigned to consume daily a beverage containing 609.3 mg catechins and 68.7 mg caffeine or a control beverage for 12 weeks. Abdominal fat area, body weight and composition were measured at week 0, week 8, and week 12. One hundred and four subjects completed the trial. Average visceral fat area, body weight, and body fat were reduced significantly by catechin-enriched green tea treatment but these effects were not seen in the control group with per-protocol sets analysis. The decrease at week 12 in the visceral fat area in the catechin group was greater than that in the control group (P = 0.04). Thus, consumption of the catechin-enriched green tea beverage for 12 weeks induced visceral fat loss in Chinese adults with a high proportion of abdominal visceral fat. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Zhang, Ying; Li, Xu; Li, Keji] Peking Univ, Sch Publ Hlth, Dept Food Hyg & Nutr, Beijing, Peoples R China.
   [Yu, Yingjie] Beijing Ctr Dis Control & Prevent, Inst Nutr & Food Safety, Beijing, Peoples R China.
   [Wang, Jingzhong] Chinese Ctr Dis Control & Prevent, Inst Nutr & Food Safety, Beijing, Peoples R China.
C3 Peking University; Chinese Center for Disease Control & Prevention
RP Li, KJ (corresponding author), Peking Univ, Sch Publ Hlth, Dept Food Hyg & Nutr, Beijing, Peoples R China.
EM ying1985love0905@yahoo.com.cn; yyj.jane.1982@163.com; xuli998@gmail.com; meguro.shinichi@kao.co.jp; hayashi.satoshi@kao.co.jp; katashima.mitsuhiro@kao.co.jp; Yasumasu.Takeshi@kao.co.jp; jingzhong.wang@yahoo.com.cn; li.keji@163.com
CR Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Hasegawa N, 2003, PHYTOTHER RES, V17, P477, DOI 10.1002/ptr.1177
   Hill AM, 2007, J AM COLL NUTR, V26, P396S, DOI 10.1080/07315724.2007.10719628
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Ikeda I, 2005, BIOSCI BIOTECH BIOCH, V69, P1049, DOI 10.1271/bbb.69.1049
   Jingzhong W, 2003, J HYGIENE RES, V32, P386
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, PR708, DOI 10.1152/ajpregu.00693.2004
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Trautwein EA, 2010, EUR J NUTR, V49, P27, DOI 10.1007/s00394-009-0045-7
   WANG H, 2009, OBESITY SILVER SPRIN, V18, P773
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yoneda T, 2009, METAB SYNDR RELAT D, V7, P349, DOI 10.1089/met.2008.0061
NR 25
TC 43
Z9 46
U1 0
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN 15
PY 2012
VL 4
IS 1
BP 315
EP 322
DI 10.1016/j.jff.2011.12.010
PG 8
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 913NN
UT WOS:000301884800036
DA 2025-04-28
ER

PT J
AU Schliep, KC
   Schisterman, EF
   Mumford, SL
   Pollack, AZ
   Zhang, CL
   Ye, AJ
   Stanford, JB
   Hammoud, AO
   Porucznik, CA
   Wactawski-Wende, J
AF Schliep, Karen C.
   Schisterman, Enrique F.
   Mumford, Sunni L.
   Pollack, Anna Z.
   Zhang, Cuilin
   Ye, Aijun
   Stanford, Joseph B.
   Hammoud, Ahmad O.
   Porucznik, Christina A.
   Wactawski-Wende, Jean
TI Caffeinated beverage intake and reproductive hormones among premenopausal women in the BioCycle Study
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID food frequency questionnaire; marginal structural models; epithelial ovarian-cancer; menstrual-cycle; genetic polymorphisms; perimenopausal women; binding globulin; cyp1a2 genotype; estrogen-levels; breast-cancer
AB Background: Caffeinated beverages are widely consumed among women of reproductive age, but their association with reproductive hormones, and whether race modifies any such associations, is not well understood. Objective: We assessed the relation between caffeine and caffeinated beverage intake and reproductive hormones in healthy premenopausal women and evaluated the potential effect modification by race. Design: Participants (n = 259) were followed for up to 2 menstrual cycles and provided fasting blood specimens for hormonal assessment at up to 8 visits per cycle and four 24-h dietary recalls per cycle. Weighted linear mixed models and nonlinear mixed models with harmonic terms were used to estimate associations between caffeine and hormone concentrations, adjusted for age, adiposity, physical activity, energy and alcohol intakes, and perceived stress. On the basis of a priori assumptions, an interaction between race and caffeine was tested, and stratified results are presented. Results: Caffeine intake >= 200 mg/d was inversely associated with free estradiol concentrations among white women (beta = -0.15; 95% CI: -0.26, -0.05) and positively associated among Asian women (beta = 0.61; 95% CI: 0.31, 0.92). Caffeinated soda intake and green tea intake >= 1 cup/d (1 cup = 240 mL) were positively associated with free estradiol concentrations among all races: beta = 0.14 (95% CI: 0.06, 0.22) and beta = 0.26 (95% CI: 0.07, 0.45), respectively. Conclusions: Moderate consumption of caffeine was associated with reduced estradiol concentrations among white women, whereas caffeinated soda and green tea intakes were associated with increased estradiol concentrations among all races. Further research is warranted on the association between caffeine and caffeinated beverages and reproductive hormones and whether these relations differ by race. Am J Clin Nutr 2012;95:488-97.
C1 [Schisterman, Enrique F.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Epidemiol Stat & Prevent Res, Rockville, MD 20852 USA.
   [Schliep, Karen C.; Stanford, Joseph B.; Porucznik, Christina A.] Univ Utah, Dept Family & Prevent Med, Salt Lake City, UT USA.
   [Hammoud, Ahmad O.] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA.
   [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA.
C3 National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; University at Buffalo, SUNY
RP Schisterman, EF (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Epidemiol Stat & Prevent Res, 6100 Execut Blvd,7B03M, Rockville, MD 20852 USA.
EM schistee@mail.nih.gov
FU Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH
CR Albert PS, 2005, BIOMETRICS, V61, P1115, DOI 10.1111/j.0006-341X.2005.464_1.x
   Anderson BL, 2009, J WOMENS HEALTH, V18, P1457, DOI 10.1089/jwh.2008.1186
   BALOGH A, 1995, EUR J CLIN PHARMACOL, V48, P161
   Brent RL, 2011, BIRTH DEFECTS RES B, V92, P152, DOI 10.1002/bdrb.20288
   Bulun SE, 1999, ENDOCR-RELAT CANCER, V6, P293, DOI 10.1677/erc.0.0060293
   BUTLER MA, 1989, P NATL ACAD SCI USA, V86, P7696, DOI 10.1073/pnas.86.20.7696
   Carl J, 2009, J FAM PRACTICE, V58, P307
   Celec P, 2010, J PSYCHOPHARMACOL, V24, P1569, DOI 10.1177/0269881109105401
   Chavarro JE, 2009, EPIDEMIOLOGY, V20, P374, DOI 10.1097/EDE.0b013e31819d68cc
   Choi Jamie H, 2011, J CAFFEINE RES, V1, P29, DOI 10.1089/jcr.2011.0001
   Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148
   Eliassen AH, 2006, JNCI-J NATL CANCER I, V98, P1406, DOI 10.1093/jnci/djj376
   Eliassen AH, 2006, J CLIN ONCOL, V24, P1823, DOI 10.1200/JCO.2005.03.7432
   Fenster L, 1999, AM J EPIDEMIOL, V149, P550, DOI 10.1093/oxfordjournals.aje.a009851
   Finkelstein JS, 2002, J CLIN ENDOCR METAB, V87, P3057, DOI 10.1210/jc.87.7.3057
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   GOLDIN BR, 1986, AM J CLIN NUTR, V44, P945, DOI 10.1093/ajcn/44.6.945
   Goodman MT, 2003, NUTR CANCER, V46, P23, DOI 10.1207/S15327914NC4601_03
   GRODSTEIN F, 1993, AM J EPIDEMIOL, V137, P1353, DOI 10.1093/oxfordjournals.aje.a116644
   Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625
   Howards PP, 2009, AM J EPIDEMIOL, V169, P105, DOI 10.1093/aje/kwn287
   Kinney A, 2007, HUM REPROD, V22, P1175, DOI 10.1093/humrep/del496
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   Kotsopoulos J, 2009, CANCER CAUSE CONTROL, V20, P335, DOI 10.1007/s10552-008-9247-1
   LIN KM, 2000, PSYCHOPHARMACOLOGY 4, V0, P0
   Lucero J, 2001, FERTIL STERIL, V76, P723, DOI 10.1016/S0015-0282(01)02005-2
   Lurie G, 2005, CANCER EPIDEM BIOMAR, V14, P1521, DOI 10.1158/1055-9965.EPI-04-0746
   Marsh EE, 2011, J CLIN ENDOCR METAB, V96, P3199, DOI 10.1210/jc.2011-1314
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   Miao YL, 2007, THERIOGENOLOGY, V68, P640, DOI 10.1016/j.theriogenology.2007.04.061
   Mizutani T, 2003, DRUG METAB REV, V35, P99, DOI 10.1081/DMR-120023681
   Monteiro R, 2008, J NUTR, V138, P2156, DOI 10.1093/jn/138.11.2156
   Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635
   Palacios N, 2010, PARKINSONISM RELAT D, V16, P370, DOI 10.1016/j.parkreldis.2010.02.012
   Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6
   Peck JD, 2010, FOOD CHEM TOXICOL, V48, P2549, DOI 10.1016/j.fct.2010.06.019
   Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011
   Rothman KJ, 2008, MORDERN EPIDEMIOLOGY, V0, P0
   Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x
   SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019
   Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264
   Schisterman EF, 2010, AM J EPIDEMIOL, V172, P430, DOI 10.1093/aje/kwq131
   Shkolnik K, 2011, P NATL ACAD SCI USA, V108, P1462, DOI 10.1073/pnas.1017213108
   SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3
   Sowers MR, 2006, AM J MED, V119, P23, DOI 10.1016/j.amjmed.2006.07.003
   Sowers MR, 2003, OSTEOPOROSIS INT, V14, P44, DOI 10.1007/s00198-002-1307-x
   Speroff L, 1999, CLIN GYNECOLOGIC END, V0, P0
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092
   Tworoger SS, 2008, CANCER-AM CANCER SOC, V112, P1169, DOI 10.1002/cncr.23275
   Wactawski-Wende J, 2009, PAEDIATR PERINAT EP, V23, P171, DOI 10.1111/j.1365-3016.2008.00985.x
   Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035
   Yamazaki H, 1998, CHEM RES TOXICOL, V11, P659, DOI 10.1021/tx970217f
   YEN SSC, 2004, YEN JAFFES REPROD DO, V0, P0
   Yong M, 2009, CANCER CAUSE CONTROL, V20, P1039, DOI 10.1007/s10552-009-9321-3
   Yoshimura N, 2002, J BONE MINER METAB, V20, P303, DOI 10.1007/s007740200044
NR 59
TC 49
Z9 60
U1 0
U2 19
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD FEB 15
PY 2012
VL 95
IS 2
BP 488
EP 497
DI 10.3945/ajcn.111.021287
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 883QC
UT WOS:000299647800029
PM 22237060
DA 2025-04-28
ER

PT J
AU Murase, T
   Yokoi, Y
   Misawa, K
   Ominami, H
   Suzuki, Y
   Shibuya, Y
   Hase, T
AF Murase, Takatoshi
   Yokoi, Yuka
   Misawa, Koichi
   Ominami, Hideo
   Suzuki, Yasuto
   Shibuya, Yusuke
   Hase, Tadashi
TI Coffee polyphenols modulate whole-body substrate oxidation and suppress postprandial hyperglycaemia, hyperinsulinaemia and hyperlipidaemia
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Chlorogenic acid; Energy metabolism; Glucosidase; Hyperglycaemia; Polyphenols
ID gastric-inhibitory polypeptide; type-2 diabetes-mellitus; chlorogenic acid; metabolic syndrome; glucose-tolerance; adipose-tissue; glycemic index; malonyl-coa; humans; risk
AB Postprandial energy metabolism, including postprandial hyperglycaemia, hyperinsulinaemia and hyperlipidaemia, is related to the risk for developing obesity and CVD. In the present study, we examined the effects of polyphenols purified from coffee (coffee polyphenols (CPP)) on postprandial carbohydrate and lipid metabolism, and whole-body substrate oxidation in C57BL/6J mice. In mice that co-ingested CPP with a lipid-carbohydrate (sucrose or starch)-mixed emulsion, the respiratory quotient determined by indirect calorimetry was significantly lower than that in control mice, whereas there was no difference in V-O2 (energy expenditure), indicating that CPP modulates postprandial energy partitioning. CPP also suppressed postprandial increases in plasma glucose, insulin, glucose-dependent insulinotropic polypeptide and TAG levels. Inhibition experiments on digestive enzymes revealed that CPP inhibits maltase and sucrase, and, to a lesser extent, pancreatic lipase in a concentration-dependent manner. Among the nine kinds of polyphenols (caffeoyl quinic acids (CQA), di-CQA, feruloyl quinic acids (FQA)) contained in CPP, di-CQA showed more potent inhibitory activity than CQA or FQA on these digestive enzymes, suggesting a predominant role of di-CQA in the regulation of postprandial energy metabolism. These results suggest that CPP modulates whole-body substrate oxidation by suppressing postprandial hyperglycaemia and hyperinsulinaemia, and these effects are mediated by inhibiting digestive enzymes.
C1 [Murase, Takatoshi; Yokoi, Yuka; Misawa, Koichi; Ominami, Hideo; Suzuki, Yasuto; Shibuya, Yusuke; Hase, Tadashi] Kao Corp, Biol Sci Labs, Ichikai, Tochigi 3213497, Japan.
C3 KAO Corporation
RP Murase, T (corresponding author), Kao Corp, Biol Sci Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.
EM murase.takatoshi@kao.co.jp
CR Aston LM, 2006, P NUTR SOC, V65, P125, DOI 10.1079/PNS2005485
   Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   BECK B, 1983, REGUL PEPTIDES, V7, P3, DOI 10.1016/0167-0115(83)90276-8
   Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223
   Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162
   Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5
   Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   COLLIER G, 1983, AM J CLIN NUTR, V37, P941, DOI 10.1093/ajcn/37.6.941
   de Paulis T, 2002, EUR J PHARMACOL, V442, P215, DOI 10.1016/S0014-2999(02)01540-6
   Després JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228
   Díaz EO, 2006, OBES REV, V7, P219, DOI 10.1111/j.1467-789X.2006.00225.x
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   ECKEL RH, 1979, DIABETES, V28, P1141, DOI 10.2337/diabetes.28.12.1141
   FLATT JP, 1995, AM J CLIN NUTR, V61, P952S, DOI 10.1093/ajcn/61.4.952S
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Guerciolini R, 1997, INT J OBESITY, V21, P0
   Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120
   IDA Y, 1994, PHYTOCHEMISTRY, V35, P209, DOI 10.1016/S0031-9422(00)90536-3
   Ishikawa A, 2007, J NUTR SCI VITAMINOL, V53, P166, DOI 10.3177/jnsv.53.166
   Iwai K, 2004, J AGR FOOD CHEM, V52, P4893, DOI 10.1021/jf040048m
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kanter JE, 2007, CIRC RES, V100, P769, DOI 10.1161/01.RES.0000259589.34348.74
   Kiso T, 2003, BIOSCI BIOTECH BIOCH, V67, P1719, DOI 10.1271/bbb.67.1719
   Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   OKeefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107
   OBEN J, 1991, J ENDOCRINOL, V130, P267, DOI 10.1677/joe.0.1300267
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344
   Scheen AJ, 2003, DRUGS, V63, P933, DOI 10.2165/00003495-200363100-00002
   Shimotoyodome A, 2009, ENDOCRINOLOGY, V150, P2118, DOI 10.1210/en.2008-1162
NR 37
TC 54
Z9 55
U1 0
U2 46
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JUN 28
PY 2012
VL 107
IS 12
BP 1757
EP 1765
DI 10.1017/S0007114511005083
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 969XJ
UT WOS:000306092400004
PM 22017960
DA 2025-04-28
ER

PT J
AU Kim, J
   Jo, I
   Joung, H
AF Kim, Jihye
   Jo, Inho
   Joung, Hyojee
TI A Rice-Based Traditional Dietary Pattern Is Associated with Obesity in Korean Adults
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
ID body-mass index; coronary-heart-disease; food-intake patterns; waist circumference; cardiovascular-disease; metabolic syndrome; national-health; weight change; life-style; women
AB Background Dietary patterns are critical in the prevention of chronic disease. The relationship between specific dietary patterns and obesity has not been evaluated in a Korean adult population. Objective This study examined whether specific dietary patterns are associated with obesity using survey data of the largest, nationally representative, general Korean population. Design The cross-sectional study was comprised of 10,089 Korean adults (19 years or older) who participated in the second and third Korean National Health and Nutrition Examination Surveys conducted in 2001 and 2005, respectively. Dietary data were assessed by 24-hour recall method. Obesity was defined as body mass index (calculated as kg/m(2)) >= 25 which is the cutoff point for adults in the Asian and Pacific regions. Results Four dietary patterns were derived using factor analysis (white rice and kimchi pattern; high-fat, sweets, and coffee pattern; meat and alcohol pattern; and grains, vegetables, and fish pattern). Each dietary pattern explained 8.6%, 6.7%, 5.7%, and 5.7% of the variation in food intake, respectively. The white rice and kimchi pattern (P for trend=0.0039) and the high-fat, sweets, and coffee pattern (P for trend=0.0054) were positively associated with obesity after adjustments for age, sex, energy intake, alcohol intake, smoking status, physical activity, and chronic diseases. No significant association was found among the meat and alcohol pattern; the grains, vegetables, and fish pattern; and obesity. Conclusions Specific dietary patterns, which include the white rice and kimchi and high-fat, sweets, and coffee patterns, may be independently associated with obesity in Korean adults. J Acad Nutr Diet. 2012;112:246-253.
C1 [Joung, Hyojee] Seoul Natl Univ, Grad Sch Publ Hlth, Sch Publ Hlth, Seoul 151742, South Korea.
   [Kim, Jihye] Daegu Univ, Dept Food & Nutr, Gyongsan, Gyeongbuk, South Korea.
   [Jo, Inho] Ewha Womans Univ, Dept Mol Med, Sch Med, Seoul, South Korea.
C3 Seoul National University (SNU); Daegu University; Ewha Womans University
RP Joung, H (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Sch Publ Hlth, Seoul 151742, South Korea.
EM hjjoung@snu.ac.kr
FU Daegu University
CR Unknown -, 2003, STATISTICS FOR EPIDEMIOLOGY, V0, P0
   Unknown -, 2000, ASIA PACIFIC PERSPEC, V0, P0
   Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Dougkas A, 2011, NUTR RES REV, V24, P72, DOI 10.1017/S095442241000034X
   FRENCH SA, 1994, INT J OBESITY, V18, P145
   Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857
   Harnden KE, 2010, J HUM NUTR DIET, V23, P3, DOI 10.1111/j.1365-277X.2009.01007.x
   Hu FB, 2000, AM J CLIN NUTR, V72, P912
   Kent LM, 2009, ASIA PAC J CLIN NUTR, V18, P453
   Kim J, 2010, EUR J CLIN NUTR, V64, P169, DOI 10.1038/ejcn.2009.131
   Kim J-O, 1978, FACTOR ANALYSIS: STATISTICAL METHODS AND PRACTICAL ISSUES, V0, P0
   Kim JA, 2007, DIABETES CARE, V30, P1904, DOI 10.2337/dc06-2591
   Kim J, 2011, J AM DIET ASSOC, V111, P1141, DOI 10.1016/j.jada.2011.05.001
   Kimokoti RW, 2010, J NUTR, V140, P1287, DOI 10.3945/jn.109.120808
   *KOR NUTR SOC, 2005, DIET REF INT KOR, V0, P0
   Lin H, 2003, J NUTR, V133, P3651, DOI 10.1093/jn/133.11.3651
   LISSNER L, 1995, EUR J CLIN NUTR, V49, P79
   Macdiarmid JI, 1998, INT J OBESITY, V22, P1053, DOI 10.1038/sj.ijo.0800724
   Martinez ME, 1998, AM J EPIDEMIOL, V148, P17, DOI 10.1093/oxfordjournals.aje.a009552
   Maskarinec G, 2000, J NUTR, V130, P3068, DOI 10.1093/jn/130.12.3068
   McNaughton SA, 2008, J NUTR, V138, P364, DOI 10.1093/jn/138.2.364
   McNaughton SA, 2007, J NUTR, V137, P99, DOI 10.1093/jn/137.1.99
   Millen BE, 2004, J AM DIET ASSOC, V104, P208, DOI 10.1016/j.jada.2003.11.007
   Ministry of Health and Welfare, 2005, NAT HLTH NUTR EX SUR, V0, P0
   Mittendorfer B, 2001, AM J CLIN NUTR, V73, P892
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   Newby PK, 2006, J NUTR, V136, P2580, DOI 10.1093/jn/136.10.2580
   Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504
   Okubo H, 2008, INT J OBESITY, V32, P541, DOI 10.1038/sj.ijo.0803737
   Park SH, 2010, INT J CARDIOL, V139, P234, DOI 10.1016/j.ijcard.2008.10.011
   Park SY, 2005, J NUTR, V135, P843, DOI 10.1093/jn/135.4.843
   Rumawas ME, 2009, AM J CLIN NUTR, V90, P1608, DOI 10.3945/ajcn.2009.27908
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Togo P, 2004, INT J OBESITY, V28, P583, DOI 10.1038/sj.ijo.0802598
   Togo P, 2001, INT J OBESITY, V25, P1741, DOI 10.1038/sj.ijo.0801819
   van Dam RM, 2003, AM J CLIN NUTR, V77, P1156, DOI 10.1093/ajcn/77.5.1156
   van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008
NR 38
TC 70
Z9 73
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 2212-2672
EI 
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD FEB 15
PY 2012
VL 112
IS 2
BP 246
EP 253
DI 10.1016/j.jada.2011.10.005
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 897MV
UT WOS:000300655700006
PM 22732459
DA 2025-04-28
ER

PT J
AU Al-Othman, A
   Al-Musharaf, S
   Al-Daghri, NM
   Yakout, S
   Alkharfy, KM
   Al-Saleh, Y
   Al-Attas, OS
   Alokail, MS
   Moharram, O
   Sabico, S
   Kumar, S
   Chrousos, GP
AF Al-Othman, Abdulaziz
   Al-Musharaf, Sara
   Al-Daghri, Nasser M.
   Yakout, Sobhy
   Alkharfy, Khalid M.
   Al-Saleh, Yousef
   Al-Attas, Omar S.
   Alokail, Majed S.
   Moharram, Osama
   Sabico, Shaun
   Kumar, Sudhesh
   Chrousos, George P.
TI Tea and coffee consumption in relation to vitamin D and calcium levels in Saudi adolescents
SO NUTRITION JOURNAL
LA English
DT Article
DE Coffee intake; Tea intake; Vitamin D levels; Saudi adolescents
ID weight-loss; postmenopausal women; caffeine consumption; risk-factors; body-mass; bone loss; metabolism; overweight; polymorphisms; thermogenesis
AB Background: Coffee and tea consumption was hypothesized to interact with variants of vitamin D-receptor polymorphisms, but limited evidence exists. Here we determine for the first time whether increased coffee and tea consumption affects circulating levels of 25-hydroxyvitamin D in a cohort of Saudi adolescents. Methods: A total of 330 randomly selected Saudi adolescents were included. Anthropometrics were recorded and fasting blood samples were analyzed for routine analysis of fasting glucose, lipid levels, calcium, albumin and phosphorous. Frequency of coffee and tea intake was noted. 25-hydroxyvitamin D levels were measured using enzyme-linked immunosorbent assays. Results: Improved lipid profiles were observed in both boys and girls, as demonstrated by increased levels of HDL-cholesterol, even after controlling for age and BMI, among those consuming 9-12 cups of coffee/week. Vitamin D levels were significantly highest among those consuming 9-12 cups of tea/week in all subjects (p-value 0.009) independent of age, gender, BMI, physical activity and sun exposure. Conclusion: This study suggests a link between tea consumption and vitamin D levels in a cohort of Saudi adolescents, independent of age, BMI, gender, physical activity and sun exposure. These findings should be confirmed prospectively.
C1 [Al-Othman, Abdulaziz; Al-Daghri, Nasser M.; Alkharfy, Khalid M.; Al-Saleh, Yousef; Al-Attas, Omar S.; Alokail, Majed S.] King Saud Univ, Prince Mutaib Chair Biomarkers Osteoporosis, Riyadh, Saudi Arabia.
   [Al-Othman, Abdulaziz] King Saud Univ, Coll Appl Med Sci, Riyadh, Saudi Arabia.
   [Al-Musharaf, Sara] King Saud Univ, Coll Sci, Womens Sect, Riyadh 11451, Saudi Arabia.
   [Al-Daghri, Nasser M.; Yakout, Sobhy; Al-Attas, Omar S.; Alokail, Majed S.; Sabico, Shaun; Chrousos, George P.] King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia.
   [Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia.
   [Alkharfy, Khalid M.] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia.
   [Al-Saleh, Yousef] King Saud Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia.
   [Moharram, Osama] King Saud Univ, King Abdulaziz Univ Hosp, Riyadh, Saudi Arabia.
   [Kumar, Sudhesh] Univ Warwick, Diabet & Metab Unit, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England.
   [Chrousos, George P.] Univ Athens, Sch Med, Dept Pediat 1, GR-11527 Athens, Greece.
   [Al-Daghri, Nasser M.] King Saud Univ, Coll Sci, Dept Biochem, Prince Mutaib Bin Abdullah Chair Osteoporosis, Riyadh 11451, Saudi Arabia.
C3 King Saud University; King Saud University; King Saud University; King Saud University; King Saud University; King Saud University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz University; King Saud University; King Abdulaziz University Hospital - Riyadh; University of Warwick; National & Kapodistrian University of Athens; Athens Medical School; King Saud University
RP Al-Daghri, NM (corresponding author), King Saud Univ, Prince Mutaib Chair Biomarkers Osteoporosis, Riyadh, Saudi Arabia.
EM aldaghri2011@gmail.com
CR Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Castellanos FX, 2002, FOOD CHEM TOXICOL, V40, P1235, DOI 10.1016/S0278-6915(02)00097-2
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   FAO, 2024, FOOD BALANCE SHEETS 20102022. GLOBAL, V0, P0
   Gates S, 1999, BRIT J CLIN PHARMACO, V47, P299, DOI 10.1046/j.1365-2125.1999.00890.x
   Gong G, 1999, OSTEOPOROSIS INT, V9, P55, DOI 10.1007/s001980050116
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710
   HASLING C, 1992, J NUTR, V122, P1119, DOI 10.1093/jn/122.5.1119
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   HealthCanada, 2003, FACT SHEET CAFF YOUR, V0, P0
   HEANEY RP, 1982, J LAB CLIN MED, V99, P46
   Heaney RP, 1996, NUTR REV, V54, P0
   Heaney RP, 2002, FOOD CHEM TOXICOL, V40, P1263, DOI 10.1016/S0278-6915(02)00094-7
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Huopio J, 2000, OSTEOPOROSIS INT, V11, P219, DOI 10.1007/s001980050284
   Izuora K, 2011, J CLIN ENDOCR METAB, V96, P2318, DOI 10.1210/jc.2010-2891
   Jorde R, 2001, EUR J EPIDEMIOL, V17, P1117, DOI 10.1023/A:1021272831251
   Kamycheva E, 2003, J NUTR, V133, P102, DOI 10.1093/jn/133.1.102
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   KREIGER N, 1992, INT J EPIDEMIOL, V21, P953, DOI 10.1093/ije/21.5.953
   MASSEY LK, 1993, J NUTR, V123, P1611, DOI 10.1093/jn/123.9.1611
   Rapuri PB, 2001, AM J CLIN NUTR, V74, P694
   Rapuri PB, 2007, J STEROID BIOCHEM, V103, P368, DOI 10.1016/j.jsbmb.2006.12.037
   Riedt CS, 2005, J BONE MINER RES, V20, P455, DOI 10.1359/JBMR.041132
   Ryu S, 2001, J NUTR SCI VITAMINOL, V47, P139, DOI 10.3177/jnsv.47.139
   Schneider C, 2009, AM FAM PHYSICIAN, V79, P591
   Spiller MA, 1998, CAFFEINE, V0, P97
   TAFT JL, 1984, BIOCHEM BIOPH RES CO, V121, P355, DOI 10.1016/0006-291X(84)90730-7
   TAGLIABUE A, 1994, INT J OBESITY, V18, P537
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tzotzas T, 2010, J CLIN ENDOCR METAB, V95, P4251, DOI 10.1210/jc.2010-0757
   ULLRICH D, 1992, EUR J CLIN PHARMACOL, V43, P167, DOI 10.1007/BF01740665
   Wood RJ, 1998, ANNU REV NUTR, V18, P233, DOI 10.1146/annurev.nutr.18.1.233
   Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004
NR 38
TC 32
Z9 33
U1 0
U2 19
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2891
EI 
J9 NUTR J
JI Nutr. J.
PD AUG 20
PY 2012
VL 11
IS 
BP 
EP 
DI 10.1186/1475-2891-11-56
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 025TZ
UT WOS:000310218900001
PM 22905922
DA 2025-04-28
ER

PT J
AU di Giuseppe, R
   Di Castelnuovo, A
   Melegari, C
   De Lucia, F
   Santimone, I
   Sciarretta, A
   Barisciano, P
   Persichillo, M
   De Curtis, A
   Zito, F
   Krogh, V
   Donati, MB
   de Gaetano, G
   Iacoviello, L
AF di Giuseppe, R.
   Di Castelnuovo, A.
   Melegari, C.
   De Lucia, F.
   Santimone, I.
   Sciarretta, A.
   Barisciano, P.
   Persichillo, M.
   De Curtis, A.
   Zito, F.
   Krogh, V.
   Donati, M. B.
   de Gaetano, G.
   Iacoviello, L.
TI Typical breakfast food consumption and risk factors for cardiovascular disease in a large sample of Italian adults
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Breakfast; Obesity; C reactive protein; Metabolic syndrome; Risk score
ID fasting lipid profiles; regular meal frequency; insulin sensitivity; dietary fiber; weight-gain; cereals; health; whole
AB Background and aims: The overall consumption of foods most frequently consumed in a typical Italian breakfast might be associated with a better cardiovascular risk profile in Italian adults. Method sand Results: 18,177 subjects (53,2% women), aged >= 35 yrs, randomly selected from the Moli-sani Project population were studied. The European Prospective Investigation into Cancer and Nutrition (EPIC) FFQ was used for dietary assessment. To derive breakfast pattern, an "a priori" approach was used: firstly, foods typical of the Italian breakfast were selected: milk, coffee, tea, yogurt, crispbread/rusks, breakfast cereals, brioche, biscuits, honey, sugar and jam. The breakfast score was obtained adding the amounts of all selected foods, expressed in grams/day, previously standardized to mean zero and standard deviation 1. Subjects showing a higher breakfast score appeared to be younger, more frequently women or smokers, with higher social status but less likely practicing physical activity. After multivariable analyses, subjects with a higher breakfast food consumption had a lower risk to have high body mass index, abdominal obesity, systolic and diastolic blood pressure, blood glucose, triglycerides, total cholesterol (P < 0.0001 for all) and C Reactive Protein (P = 0.022). The associations were unrelated to age, sex, smoking, obesity, physical activity and social status. Subjects with a higher food breakfast score also showed a better physical healthy status score, a lower risk of metabolic syndrome (OR = 0.63; 0.55-0.72 95% CI) and of future CVD (P < 0.0001 for both women and men). Conclusion: Consumption of typical Italian breakfast foods positively affects CVD risk profile in an adult Italian population. (c) 2010 Elsevier B.V. All rights reserved.
C1 [di Giuseppe, R.; Di Castelnuovo, A.; De Lucia, F.; Santimone, I.; Sciarretta, A.; Barisciano, P.; Persichillo, M.; De Curtis, A.; Zito, F.; Donati, M. B.; de Gaetano, G.; Iacoviello, L.] Catholic Univ, John Paul II Ctr High Technol Res & Educ Biomed S, Lab Genet & Environm Epidemiol, Res Labs, I-86100 Campobasso, Italy.
   [Melegari, C.] Barilla Spa, Parma, Italy.
   [Krogh, V.] Natl Canc Inst, Nutr Epidemiol Unit, I-20133 Milan, Italy.
C3 Catholic University of the Sacred Heart; Fondazione IRCCS Istituto Nazionale Tumori Milan
RP Iacoviello, L (corresponding author), Catholic Univ, John Paul II Ctr High Technol Res & Educ Biomed S, Lab Genet & Environm Epidemiol, Res Labs, Largo Gemelli 1, I-86100 Campobasso, Italy.
EM licia.iacoviello@rm.unicatt.it
FU Associazione Cuore Sano (Campobasso, Italy); Instrumentation Laboratory (IL, Milano, Italy); Derby Blue (San Lazzaro di Savena, Bologna, Italy); Caffe' Monforte (Campobasso, Italy); Pfizer Foundation (Rome, Italy); Italian Ministry of University and Research (MIUR, Rome, Italy) [1588]; Barilla SpA. Parma. Italy
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, PS498, DOI 10.1097/00005768-200009001-00009
   Bazzano LA, 2005, OBES RES, V13, P1952, DOI 10.1038/oby.2005.240
   Brighenti F, 1999, EUR J CLIN NUTR, V53, P726, DOI 10.1038/sj.ejcn.1600841
   Centritto F, 2009, NUTR METAB CARDIOVAS, V19, P697, DOI 10.1016/j.numecd.2008.11.009
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Farshchi HR, 2005, AM J CLIN NUTR, V81, P388
   Farshchi HR, 2005, AM J CLIN NUTR, V81, P16
   Farshchi HR, 2004, EUR J CLIN NUTR, V58, P1071, DOI 10.1038/sj.ejcn.1601935
   Giampaoli Simona, 2004, ITAL HEART J SUPPL, V5, P177
   Howarth NC, 2001, NUTR REV, V59, P129, DOI 10.1111/j.1753-4887.2001.tb07001.x
   Lacoviello L, 2007, EPIDEMIOL BIOSTAT PU, V4, P110
   Lazzeri G, 2006, J PREV MED HYG, V47, P91
   Liese AD, 2003, AM J CLIN NUTR, V78, P965, DOI 10.1093/ajcn/78.5.965
   Liu SM, 2003, AM J CLIN NUTR, V77, P594, DOI 10.1093/ajcn/77.3.594
   McIntosh M, 2001, NUTR REV, V59, P52
   Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001
   Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002
   Pala V, 2003, TUMORI J, V89, P594, DOI 10.1177/030089160308900603
   Pereira Mark A, 1998, CVD PREV, V1, P231
   Pisani P, 1997, INT J EPIDEMIOL, V26, PS152, DOI 10.1093/ije/26.suppl_1.S152
   Slavin JL, 2005, NUTRITION, V21, P411, DOI 10.1016/j.nut.2004.08.018
   Timlin MT, 2007, NUTR REV, V65, P268, DOI 10.1301/nr.2007.jun.268-281
   Vanelli Maurizio, 2005, ACTA BIOMED, V76, P79
   Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008
   Warensjö E, 2010, AM J CLIN NUTR, V92, P194, DOI 10.3945/ajcn.2009.29054
   Willet WC, 1998, NUTRITIONAL EPIDEMIOLOGY, V0, P0, DOI DOI 10.1093/acprof:oso/9780195122978.001.0001
   Wyatt HR, 2002, OBES RES, V10, P78, DOI 10.1038/oby.2002.13
NR 29
TC 38
Z9 38
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD APR 15
PY 2012
VL 22
IS 4
BP 347
EP 354
DI 10.1016/j.numecd.2010.07.006
PG 8
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition & Dietetics
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism; Nutrition & Dietetics
GA 912LW
UT WOS:000301800500007
PM 21093229
DA 2025-04-28
ER

PT J
AU Yakubo, S
   Ueda, Y
   Tanekura, N
   Okudaira, T
   Namiki, T
   Shimabukuro, H
   Arashima, Y
AF Yakubo, Shuji
   Ueda, Yukiko
   Tanekura, Naomichi
   Okudaira, Tomoyuki
   Namiki, Takao
   Shimabukuro, Hiroaki
   Arashima, Yasutomo
TI Thermogenic Effect of Bofu-Tsusho-San on Human Interscapular Adipose Tissue
SO INTERNATIONAL MEDICAL JOURNAL
LA English
DT Article
DE Bofu-tsusho-San; Kampo medicine; obesity; thermogenesis; addipose tissue
ID metabolic-syndrome; uncoupling proteins; ephedrine; obese; mice; caffeine; rats; ucp1
AB Purpose of the study: Bofu-tsusho-San (Fang-feng-tong-sheng-san) has been used to treat obesity for about 700 years in China and Japan. In mice, the anti-obesity actions of Tsumura Bofu-tsusho-San extract granules (Tokyo, Japan)(TJ-62) have been shown to include promotion in brown adipose tissue (BAT) thermogenesis via l-ephedrine and d-pseudoephedrine, as well as inhibition of phosphodiesterase activity. And it was reported that TJ-62 has actions to decrease the weight and size gains of white adipose tissue (WAT) along with up-regulating uncoupling protein (UCP)1 mRNA in WAT of high-fat mice. We investigated in human activating thermogenesis of adipose tissue by TJ-62. Material and methods: We studied 6 healthy subjects. As control, we administered 150 ml of hot water (60 degrees C). On another day, we administered TJ-62 (5.0 g) and 150 ml of hot water (60 degrees C). We investigated the thermogenic effect of TJ-62 on human interscapular adipose tissue including BAT and WAT with a CM-210 (Terumo Co. Ltd., Tokyo, Japan). Results: We found that the interscapular area of the back showed a higher temperature from 10 minutes after oral administration of TJ-62, and it was higher than after administration of the control. No significant changes of chest temperature occurred, an area where little adipose tissue exists. Conclusion: We think that the anti-obesity action of TJ-62 is based on activating thermogenesis of adipose tissue in human.
C1 [Yakubo, Shuji; Ueda, Yukiko; Tanekura, Naomichi; Okudaira, Tomoyuki] Nihon Univ, Sch Med, Dept Med, Div Integrated Herbal Med,Itabashi Ku, Tokyo 1738610, Japan.
   [Namiki, Takao] Chiba Univ, Grad Sch Med, Dept Japanese Oriental Kampo Med, Chuo Ku, Chiba 2608670, Japan.
   [Shimabukuro, Hiroaki] Nihon Univ, Itabashi Hosp, Clin Lab, Itabashi Ku, Tokyo 1738610, Japan.
   [Arashima, Yasutomo] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Lab Med,Itabashi Ku, Tokyo 1738610, Japan.
C3 Nihon University; Chiba University; Nihon University; Nihon University
RP Arashima, Y (corresponding author), Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Lab Med,Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.
EM ara1145145@gmail.com
CR Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022
   ARCH JRS, 1982, LIFE SCI, V30, P1817, DOI 10.1016/0024-3205(82)90319-8
   Argilés JM, 2002, BIOCHEM BIOPH RES CO, V293, P1145, DOI 10.1016/S0006-291X(02)00355-8
   Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001
   DULLOO AG, 1991, INT J OBESITY, V15, P317
   DULLOO AG, 1989, NUTRITION, V5, P7
   EVANS E, 1977, P NUTR SOC, V36, P0
   Hioki C, 2004, CLIN EXP PHARMACOL P, V31, P614, DOI 10.1111/j.1440-1681.2004.04056.x
   HOTON TJ, 1990, P NUTR SOC, V49, P0
   Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, PE1014, DOI 10.1152/ajpendo.00105.2005
   Kampo Terasawa K, 1993, JAPANESE ORIENTAL ME, V0, P248
   Liu YC, 2006, BIOSCI BIOTECH BIOCH, V70, P2733, DOI 10.1271/bbb.60349
   Matsukawa T, 1996, EUR J ANAESTH, V13, P340, DOI 10.1046/j.1365-2346.1996.00974.x
   Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751
   Narita O, 1983, SANKA TO FUJINKA, V2, P123
   Ordovas JM, 2008, KIDNEY INT, V74, PS10, DOI 10.1038/ki.2008.517
   Tchernof A, 2007, NUTR REV, V65, PS24, DOI 10.1301/nr.2007.jun.S24-S29
   Ueda Y, 2012, INT MED J, V19, P314
   Yamakawa K, 1993, KAMPO MED, V17, P424
   YOSHIDA T, 1995, INT J OBESITY, V19, P717
NR 20
TC 0
Z9 0
U1 0
U2 5
PU JAPAN INT CULTURAL EXCHANGE FOUNDATION
PI TOKYO
PA 2-15-5-207, SHOTO, SHIBUYA-KU, TOKYO, 150-0046, JAPAN
SN 1341-2051
EI 
J9 INT MED J
JI Int. Med. J.
PD DEC 15
PY 2012
VL 19
IS 4
BP 378
EP 381
DI 
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA 078WY
UT WOS:000314132300029
DA 2025-04-28
ER

PT J
AU Nilsson, LM
   Winkvist, A
   Brustad, M
   Jansson, JH
   Johansson, I
   Lenner, P
   Lindahl, B
   Van Guelpen, B
AF Nilsson, Lena Maria
   Winkvist, Anna
   Brustad, Magritt
   Jansson, Jan-Hakan
   Johansson, Ingegerd
   Lenner, Per
   Lindahl, Bernt
   Van Guelpen, Bethany
TI A traditional Sami diet score as a determinant of mortality in a general northern Swedish population
SO INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH
LA English
DT Article
DE the VIP cohort; Sami, traditional food; traditional lifestyle; mortality
ID life-style; myocardial-infarction; energy-intake; health; disease; sweden; cancer; coffee; food; consumption
AB Objectives. To examine the relationship between "traditional Sami" dietary pattern and mortality in a general northern Swedish population. Study design. Population-based cohort study. Methods. We examined 77,319 subjects from the Vasterbotten Intervention Program (VIP) cohort. A traditional Sami diet score was constructed by adding 1 point for intake above the median level of red meat, fatty fish, total fat, berries and boiled coffee, and 1 point for intake below the median of vegetables, bread and fibre. Hazard ratios (HR) for mortality were calculated by Cox regression. Results. Increasing traditional Sami diet scores were associated with slightly elevated all-cause mortality in men [Multivariate HR per 1-point increase in score 1.04 (95% CI 1.01-1.07), p = 0.018], but not for women [Multivariate HR 1.03 (95% CI 0.99-1.07), p = 0.130]. This increased risk was approximately equally attributable to cardiovascular disease and cancer, though somewhat more apparent for cardiovascular disease mortality in men free from diabetes, hypertension and obesity at baseline [Multivariate HR 1.10 (95% CI 1.01 1.20), p = 0.023]. Conclusions. A weak increased all-cause mortality was observed in men with higher traditional Sami diet scores. However, due to the complexity in defining a "traditional Sami" diet, and the limitations of our questionnaire for this purpose, the study should be considered exploratory, a first attempt to relate a "traditional Sami" dietary pattern to health endpoints. Further investigation of cohorts with more detailed information on dietary and lifestyle items relevant for traditional Sami culture is warranted.
C1 [Nilsson, Lena Maria; Jansson, Jan-Hakan; Lindahl, Bernt] Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden.
   [Winkvist, Anna] Univ Gothenburg, Dept Internal Med & Clin Nutr, Sahlgrenska Acad, Gothenburg, Sweden.
   [Brustad, Magritt] Univ Tromso, Ctr Sami Hlth Res, Dept Community Med, Tromso, Norway.
   [Jansson, Jan-Hakan] Skelleftea Hosp, Dept Med, Skelleftea, Sweden.
   [Johansson, Ingegerd] Umea Univ, Dept Odontol, SE-90185 Umea, Sweden.
   [Lenner, Per] Umea Univ, Dept Oncol & Radiat Sci, Ctr Oncol, SE-90185 Umea, Sweden.
   [Van Guelpen, Bethany] Umea Univ, Dept Med Biosci, SE-90185 Umea, Sweden.
C3 Umea University; University of Gothenburg; UiT The Arctic University of Tromso; Umea University; Umea University; Umea University
RP Nilsson, LM (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden.
EM lena.nilsson@nutrires.umu.se
FU HELGA/Nordforsk; Joint Committee of Northern Sweden Healthcare Region; Vasterbotten County Council; Swedish Research Council; Swedish Council for Working Life and Social Research
CR Unknown -, 1983, KUNGLIGA SKYTTEANSKA, V0, P0
   Bere E, 2007, EUR J CLIN NUTR, V61, P431, DOI 10.1038/sj.ejcn.1602512
   Bere E, 2009, PUBLIC HEALTH NUTR, V12, P91, DOI 10.1017/S1368980008001985
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Brustad M, 2008, INT J CIRCUMPOL HEAL, V67, P82
   Chung N, 2008, INT J CLIN PRACT, V62, P1306, DOI 10.1111/j.1742-1241.2008.01838.x
   Downward G, 2011, THESIS UMEA U UMEA, V0, P0
   Drake S, 1918, VASTERBOTTENSLAPPARN, V0, P0
   Elenius L, 2006, NATIONALSTAT MINORIT, V0, P212
   Fjellstrom P, 1985, SAMERNAS SAMHALLE I TRADITION OCH NUTID LAPPISH SOCIETY IN TRADITION AND THE PRESENT DAY, V0, P0
   Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4
   Haglin L, 1991, ARCTIC MED RES, VSuppl, P741
   Hammar N, 2003, J INTERN MED, V253, P653, DOI 10.1046/j.1365-2796.2003.01142.x
   Haraldson S, 1962, LAKARTIDNINGEN, V59, P2829
   Hassan AA, 2012, INT J CIRCUMPOL HEAL, V71, P0, DOI 10.3402/ijch.v71i0.18187
   Hassler S, 2005, INT J EPIDEMIOL, V34, P623, DOI 10.1093/ije/dyi027
   Hassler S, 2008, INT J CIRCUMPOL HEAL, V67, P421, DOI 10.3402/ijch.v67i5.18351
   Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569
   Johansson G, 2008, INT J OBESITY, V32, P1031, DOI 10.1038/ijo.2008.42
   Johansson H, 1975, FORSKARE BEFOLKNINGS, V0, P0
   Johansson I, 2010, EUR J CLIN NUTR, V64, P905, DOI 10.1038/ejcn.2010.80
   Johansson I, 2002, PUBLIC HEALTH NUTR, V5, P487, DOI 10.1079/PHN2001315
   Kozlov A, 1997, ANTHROPOL ANZ, V55, P293
   Kozlov A, 2008, INT J CIRCUMPOL HEAL, V67, P56
   Michels KB, 2003, INT J EPIDEMIOL, V32, P486, DOI 10.1093/ije/dyg216
   MIETTINEN JK, 1964, RADIOL HLTH DATA, V5, P83
   Morkenstam U, 2000, KOMPLEXA KONTINENTEN, V0, P267
   Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885
   Naqshbandi M, 2008, DIABETES RES CLIN PR, V82, P1, DOI 10.1016/j.diabres.2008.07.017
   Nilsson LM, 2010, NUTR METAB CARDIOVAS, V20, P527, DOI 10.1016/j.numecd.2009.05.004
   Nilsson LM, 2011, INT J CIRCUMPOL HEAL, V70, P301, DOI 10.3402/ijch.v70i3.17831
   Nilsson LM, 2010, CANCER CAUSE CONTROL, V21, P1533, DOI 10.1007/s10552-010-9582-x
   Nystad T, 2010, PUBLIC HEALTH NUTR, V13, P1818, DOI 10.1017/S1368980010000376
   ODIN M, 1934, SOCIALHYGIENISK UN 2, V0, P8
   Olsen A, 2011, J NUTR, V141, P639, DOI 10.3945/jn.110.131375
   Pukkala E, 2007, ACTA ONCOL, V46, P286, DOI 10.1080/02841860701203545
   Ross AB, 2006, CROAT MED J, V47, P553
   Ross AB, 2009, INT J CIRCUMPOL HEAL, V68, P372, DOI 10.3402/ijch.v68i4.17371
   Sjolander P, 2011, GLOB HLTH ACTION, V4, P1
   Sjölander P, 2008, SCAND J PUBLIC HEALT, V36, P84, DOI 10.1177/1403494807085305
   Sköold P, 2008, INT J CIRCUMPOL HEAL, V67, P27
   Sofi F, 2008, BMJ-BRIT MED J, V337, P0, DOI 10.1136/bmj.a1344
   Turi J, 1987, BOK SAMERNAS LIV MUI, V0, P0
   Weinehall L, 1998, SCAND J PRIM HEALTH, V16, P171
   Wennberg M, 2011, AM J CLIN NUTR, V93, P27, DOI 10.3945/ajcn.2010.29408
   Wennberg M, 2009, PUBLIC HEALTH NUTR, V12, P1477, DOI 10.1017/S1368980008004503
   Wiklund K, 1991, ARCTIC MED RES, V50, P3
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
   Winkvist A, 2009, NUTR J, V8, P0, DOI 10.1186/1475-2891-8-12
   World Cancer Research Fund, 2007, FOOD NUTR PHYS ACT P, V0, P63
NR 51
TC 23
Z9 25
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1239-9736
EI 2242-3982
J9 INT J CIRCUMPOL HEAL
JI Int. J. Circumpolar Health
PD JUN 15
PY 2012
VL 71
IS 
BP 
EP 
DI 10.3402/ijch.v71i0.18537
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 998JC
UT WOS:000308232900001
PM 22584519
DA 2025-04-28
ER

PT J
AU Fung, TT
   Hu, FB
   Schulze, M
   Pollak, M
   Wu, TY
   Fuchs, CS
   Giovannucci, E
AF Fung, Teresa T.
   Hu, Frank B.
   Schulze, Matthias
   Pollak, Michael
   Wu, Tianying
   Fuchs, Charles S.
   Giovannucci, Edward
TI A dietary pattern that is associated with C-peptide and risk of colorectal cancer in women
SO CANCER CAUSES & CONTROL
LA English
DT Article
DE Colorectal cancer; Diet; C-peptide
ID growth-factor-i; cardiovascular-disease; decaffeinated coffee; binding-proteins; insulin index; load; reproducibility; biomarkers; validity
AB Higher serum C-peptide concentrations have shown to be associated with an increased risk of colorectal cancer (CRC). Therefore, we used diet information to identify food groups that correlated with fasting serum concentrations of C-peptide and assess the association of this dietary pattern and CRC risk. Major food contributors to fasting C-peptide concentrations were identified with stepwise linear regression in a subsample ( = 833) of women from a large cohort. We then summed the consumption frequency of the major food contributors to form a C-peptide dietary pattern for the entire cohort ( = 66,714). Risk for CRC was computed using Cox proportional hazard model with the C-peptide dietary pattern score as the predictor. In up to 20 years of follow-up, we ascertained 985 cases of CRC and 758 colon cancer. After adjusting for confounders, the C-peptide dietary pattern, characterized by higher meat, fish, and sweetened beverage intake, but lower coffee, high fat dairy, and whole grains intake, showed direct association with CRC risk (RR comparing extreme quintiles = 1.29, 95 % CI = 1.05-1.58, trend = 0.048). The same comparison was slightly stronger for colon cancer (RR = 1.35, 95 % CI = 1.07-1.70, trend = 0.009). In stratified analysis, there was no association between the C-peptide dietary pattern and colon cancer among lean and active women. However, for overweight or sedentary women, RR for the same comparison was 1.58 (95 % CI = 1.20-2.07, trend = 0.002) ( for interaction = 0.007). We derived a dietary pattern that correlated with C-peptide concentrations. This pattern was associated with an increase in colon cancer, especially among women who were overweight or sedentary.
C1 [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA.
   [Fung, Teresa T.; Hu, Frank B.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Hu, Frank B.; Giovannucci, Edward] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA.
   [Hu, Frank B.; Giovannucci, Edward] Harvard Univ, Sch Med, Boston, MA USA.
   [Schulze, Matthias] Tech Univ Munich, Munich, Germany.
   [Schulze, Matthias] German Inst Human Nutr, Munich, Germany.
   [Pollak, Michael] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada.
   [Wu, Tianying] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA.
   [Fuchs, Charles S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.
C3 Simmons University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Technical University of Munich; Leibniz Association; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Lady Davis Institute; McGill University; University System of Ohio; University of Cincinnati; Harvard University; Harvard University Medical Affiliates; Dana-Farber Cancer Institute
RP Fung, TT (corresponding author), Simmons Coll, Dept Nutr, 300 Fenway, Boston, MA 02115 USA.
EM fung@simmons.edu
FU National Institute of Health [CA87969, HL60712, CA95589]
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, PS498, DOI 10.1097/00005768-200009001-00009
   Bao Y, 2010, CANCER EPIDEM BIOMAR, V19, P3020, DOI 10.1158/1055-9965.EPI-10-0833
   Bobe G, 2010, CANCER EPIDEM BIOMAR, V19, P1441, DOI 10.1158/1055-9965.EPI-09-1082
   COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319
   FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   Giovannucci E, 2004, INT J EPIDEMIOL, V33, P217, DOI 10.1093/ije/dyh020
   Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078
   Giovannucci EL, 1995, CANCER CAUSE CONTROL, V164- 179, P16
   Gnagnarella P, 2008, AM J CLIN NUTR, V87, P1793, DOI 10.1093/ajcn/87.6.1793
   Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697
   Jensen MK, 2006, AM J CLIN NUTR, V83, P275
   Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592
   Kerver JM, 2003, AM J CLIN NUTR, V78, P1103, DOI 10.1093/ajcn/78.6.1103
   Le Marchand L, 2010, CANCER EPIDEM BIOMAR, V19, P1471, DOI 10.1158/1055-9965.EPI-10-0128
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   McNaughton SA, 2008, DIABETES CARE, V31, P1343, DOI 10.2337/dc07-1946
   Nimptsch K, 2011, AM J CLIN NUTR, V94, P182, DOI 10.3945/ajcn.110.009555
   Ning Y, 2010, OBES REV, V11, P19, DOI 10.1111/j.1467-789X.2009.00613.x
   Otani T, 2007, INT J CANCER, V120, P2007, DOI 10.1002/ijc.22556
   Rosner B, 2008, AM J EPIDEMIOL, V167, P653, DOI 10.1093/aje/kwm348
   Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661
   Willett WC, 1998, NUTR EPIDEMIOLOGY, V0, P0
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
NR 26
TC 31
Z9 33
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-5243
EI 1573-7225
J9 CANCER CAUSE CONTROL
JI Cancer Causes Control
PD JUN 15
PY 2012
VL 23
IS 6
BP 959
EP 965
DI 10.1007/s10552-012-9969-y
PG 7
WC Oncology; Public, Environmental & Occupational Health
SC Oncology; Public, Environmental & Occupational Health
GA 943FK
UT WOS:000304105700017
PM 22535146
DA 2025-04-28
ER

PT J
AU Hansen, DK
   George, NI
   White, GE
   Pellicore, LS
   Abdel-Rahman, A
   Fabricant, D
AF Hansen, Deborah K.
   George, Nysia I.
   White, Gene E.
   Pellicore, Linda S.
   Abdel-Rahman, Ali
   Fabricant, Daniel
TI Physiological effects following administration of Citrus aurantium for 28 days in rats
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Bitter orange; Citrus aurantium; Cardiotoxicology; Blood pressure; Heart rate; Weight loss
ID weight-loss supplements; bitter-orange; dietary-supplements; ephedra-free; synephrine stereoisomers; p-synephrine; caffeine; overweight; alkaloids; extract
AB Background: Since ephedra-containing dietary supplements were banned from the US market, manufacturers changed their formulations by eliminating ephedra and replacing with other botanicals, including Citrus aurantium, or bitter orange. Bitter orange contains, among other compounds, synephrine, a chemical that is chemically similar to ephedrine. Since ephedrine may have cardiovascular effects, the goal of this study was to investigate the cardiovascular effects of various doses of bitter orange extract and pure synephrine in rats. Method: Female Sprague-Dawley rats were dosed daily by gavage for 28 days with synephrine from two different extracts. One extract contained 6% synephrine, and the other extract contained 95% synephrine. Doses were 10 or 50 mg synephrine/kg body weight from each extract. Additionally, caffeine was added to these doses, since many dietary supplements also contain caffeine. Telemetry was utilized to monitor heart rate, blood pressure, body temperature and QT interval in all rats. Results and conclusion: Synephrine, either as the bitter orange extract or as pure synephrine, increased heart rate and blood pressure. Animals treated with 95% synephrine showed minimal effects on heart rate and blood pressure; more significant effects were observed with the bitter orange extract suggesting that other components in the botanical can alter these physiological parameters. The increases in heart rate and blood pressure were more pronounced when caffeine was added. None of the treatments affected uncorrected QT interval in the absence of caffeine. Published by Elsevier Inc.
C1 [Hansen, Deborah K.; George, Nysia I.] US FDA, Div Personalized Nutr & Med, NCTR, Jefferson, AR 72079 USA.
   [White, Gene E.] Toxicol Pathol Associates, Jefferson, AR 72079 USA.
   [Pellicore, Linda S.] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA.
   [Abdel-Rahman, Ali; Fabricant, Daniel] US FDA, Off Nutr Labeling & Dietary Supplements, Ctr Food Safety & Nutr, College Pk, MD 20740 USA.
C3 US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)
RP Hansen, DK (corresponding author), US FDA, Div Personalized Nutr & Med, NCTR, 3900 NCTR Rd, Jefferson, AR 72079 USA.
EM deborah.hansen@fda.hhs.gov
FU FDA:NCTR; NIEHS:NTP [FDA 224-07-0007, NIH Y1ES1027]
CR Allison DB, 2005, INT J OBESITY, V29, P443, DOI 10.1038/sj.ijo.0802879
   Andrews KW, 2007, ANAL BIOANAL CHEM, V389, P231, DOI 10.1007/s00216-007-1437-2
   Arbo MD, 2008, FOOD CHEM TOXICOL, V46, P2770, DOI 10.1016/j.fct.2008.04.037
   Arbo MD, 2009, REGUL TOXICOL PHARM, V54, P114, DOI 10.1016/j.yrtph.2009.03.001
   Bent S, 2004, AM J CARDIOL, V94, P1359, DOI 10.1016/j.amjcard.2004.07.137
   Blanck HM, 2007, J AM DIET ASSOC, V107, P441, DOI 10.1016/j.jada.2006.12.009
   Bouchard NC, 2005, MAYO CLIN PROC, V80, P541, DOI 10.4065/80.4.541
   BROWN CM, 1988, BRIT J PHARMACOL, V93, P417, DOI 10.1111/j.1476-5381.1988.tb11449.x
   Bui LT, 2006, ANN PHARMACOTHER, V40, P53, DOI 10.1345/aph.1G488
   Calapai G, 1999, FITOTERAPIA, V70, P586, DOI 10.1016/S0367-326X(99)00093-3
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   Evans RL, 2008, J CHROMATOGR SCI, V46, P61, DOI 10.1093/chromsci/46.1.61
   Fang YS, 2009, PLANTA MED, V75, P24, DOI 10.1055/s-0028-1088342
   Firenzuoli F, 2005, PHYTOMEDICINE, V12, P247, DOI 10.1016/j.phymed.2004.02.005
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   Gange CA, 2006, MAYO CLIN PROC, V81, P545, DOI 10.4065/81.4.545
   Gray S, 2005, J ADOLESCENT HEALTH, V37, P415, DOI 10.1016/j.jadohealth.2004.12.011
   Haaz S, 2006, OBES REV, V7, P79, DOI 10.1111/j.1467-789X.2006.00195.x
   Haller CA, 2005, AM J MED, V118, P998, DOI 10.1016/j.amjmed.2005.02.034
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Haller CA, 2008, BRIT J CLIN PHARMACO, V65, P833, DOI 10.1111/j.1365-2125.2008.03144.x
   Hamer M, 2006, J HUM HYPERTENS, V20, P909, DOI 10.1038/sj.jhh.1002076
   Holmes RO, 2008, MIL MED, V173, P708, DOI 10.7205/MILMED.173.7.708
   HUANG YT, 1995, LIFE SCI, V57, P2011, DOI 10.1016/0024-3205(95)02195-O
   Ilbäck NG, 2007, FOOD CHEM TOXICOL, V45, P834, DOI 10.1016/j.fct.2006.11.001
   JORDAN R, 1987, J PHARM PHARMACOL, V39, P752, DOI 10.1111/j.2042-7158.1987.tb06986.x
   Kalman D, 2002, INT J OBESITY, V26, P1363, DOI 10.1038/sj.ijo.0802061
   Kalman DS, 2004, INT J OBESITY, V28, P1355, DOI 10.1038/sj.ijo.0802418
   Kalman DS, 2000, CURR THER RES CLIN E, V61, P199, DOI 10.1016/S0011-393X(00)89034-7
   Klontz KC, 2006, ANN PHARMACOTHER, V40, P1747, DOI 10.1345/aph.1H196
   Knight CA, 2004, FOOD CHEM TOXICOL, V42, P1923, DOI 10.1016/j.fct.2004.05.002
   Marcus DM, 2003, SCIENCE, V301, P1669
   Min B, 2005, PHARMACOTHERAPY, V25, P1719, DOI 10.1592/phco.2005.25.12.1719
   Nasir JM, 2004, MAYO CLIN PROC, V79, P1059, DOI 10.4065/79.8.1059
   Nykamp DL, 2004, ANN PHARMACOTHER, V38, P812, DOI 10.1345/aph.1D473
   Pellati F, 2007, J CHROMATOGR A, V1161, P71, DOI 10.1016/j.chroma.2007.05.097
   Penzak SR, 2001, J CLIN PHARMACOL, V41, P1059, DOI 10.1177/00912700122012652
   Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136
   Riksen Niels P, 2011, HANDB EXP PHARMACOL, V0, PP413, DOI 10.1007/978-3-642-13443-2_16
   Rossato LG, 2011, ARCH TOXICOL, V85, P929, DOI 10.1007/s00204-010-0630-9
   Rossato LG, 2011, FOOD CHEM TOXICOL, V49, P8, DOI 10.1016/j.fct.2010.11.007
   Sale C, 2006, INT J OBESITY, V30, P764, DOI 10.1038/sj.ijo.0803209
   Santana J, 2008, FOOD CHEM, V109, P675, DOI 10.1016/j.foodchem.2007.12.076
   Sharpe PA, 2006, J AM DIET ASSOC, V106, P2045, DOI 10.1016/j.jada.2006.09.014
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Stephensen TA, 2009, MIL MED, V174, P1313, DOI 10.7205/MILMED-D-01-5009
   Stohs SJ, 2011, PHYTOTHER RES, V25, P1421, DOI 10.1002/ptr.3490
   Stohs SJ, 2011, OXID MED CELL LONGEV, V2011, P0, DOI 10.1155/2011/482973
   Sultan S, 2006, MAYO CLIN PROC, V81, P1630, DOI 10.4065/81.12.1630
   Thomas JE, 2009, TEX HEART I J, V36, P586
   Westfall TC, 2006, GOODMAN AND GILMANS THE PHARMACOLOGICAL BASIS OF THERAPEUTICS, V11th, P237
NR 53
TC 22
Z9 24
U1 0
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD JUN 15
PY 2012
VL 261
IS 3
BP 236
EP 247
DI 10.1016/j.taap.2012.04.006
PG 12
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 961XK
UT WOS:000305502600002
PM 22521485
DA 2025-04-28
ER

PT J
AU Kerr, J
   Frank, L
   Sallis, JF
   Saelens, B
   Glanz, K
   Chapman, J
AF Kerr, Jacqueline
   Frank, Lawrence
   Sallis, James F.
   Saelens, Brian
   Glanz, Karen
   Chapman, Jim
TI Predictors of trips to food destinations
SO INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
LA English
DT Article
DE Built environment; Food environment; Urban form; Travel; Nutrition; Obesity
ID physical-activity; neighborhood characteristics; store availability; environment; obesity; associations; access; disparity; location; dietary
AB Background: Food environment studies have focused on ethnic and income disparities in food access. Few studies have investigated distance travelled for food and did not aim to inform the geographic scales at which to study the relationship between food environments and obesity. Further, studies have not considered neighborhood design as a predictor of food purchasing behavior. Methods: Atlanta residents (N = 4800) who completed a travel diary and reported purchasing or consuming food at one of five food locations were included in the analyses. A total of 11,995 food-related trips were reported. Using mixed modeling to adjust for clustering of trips by participants and households, person-level variables (e.g. demographics), neighborhood-level urban form measures, created in GIS, and trip characteristics (e.g. time of day, origin and destination) were investigated as correlates of distance travelled for food and frequency of grocery store and fast food outlet trips. Results: Mean travel distance for food ranged from 4.5 miles for coffee shops to 6.3 miles for superstores. Type of store, urban form, type of tour, day of the week and ethnicity were all significantly related to distance travelled for food. Origin and destination environment, type of tour, day of week, age, gender, income, ethnicity, vehicle access and obesity status were all significantly related to visiting a grocery store. Home neighborhood environment, day of week, type of tour, gender, income, education level, age, and obesity status were all significantly related to likelihood of visiting a fastfood outlet. Conclusions: The present study demonstrated that people travel sizeable distances for food and this distance is related to urban. Results suggest that researchers need to employ different methods to characterize food environments than have been used to assess urban form in studies of physical activity. Food is most often purchased while traveling from locations other than home, so future studies should assess the food environment around work, school or other frequently visited destinations, as well as along frequently traveled routes.
C1 [Kerr, Jacqueline; Sallis, James F.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Frank, Lawrence] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.
   [Sallis, James F.] San Diego State Univ, San Diego, CA 92182 USA.
   [Saelens, Brian] Seattle Childrens Res Inst, Washington, DC USA.
   [Saelens, Brian] Univ Washington, Washington, DC USA.
   [Glanz, Karen] Univ Penn, Philadelphia, PA 19104 USA.
   [Chapman, Jim] Urban Design Hlth, Washington, DC USA.
C3 University of California System; University of California San Diego; University of British Columbia; California State University System; San Diego State University; University of Washington; University of Pennsylvania
RP Kerr, J (corresponding author), Univ Calif San Diego, San Diego, CA 92103 USA.
EM jkerr@ucsd.edu
CR Alwitt LF, 1997, J CONSUM AFF, V31, P139, DOI 10.1111/j.1745-6606.1997.tb00830.x
   Unknown -, 1949, HUMAN BEHAVIOUR AND THE PRINCIPLE OF LEAST-EFFORT, V0, P0
   Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341
   Block D, 2006, PUBLIC HEALTH NUTR, V9, P837, DOI 10.1017/PHN2005924
   Booth KM, 2005, J AM DIET ASSOC, V105, PS110, DOI 10.1016/j.jada.2005.02.045
   Bowman JL, 2001, TRANSPORT RES A-POL, V35, P1, DOI 10.1016/S0965-8564(99)00043-9
   Braza M, 2004, AM J HEALTH PROMOT, V19, P128, DOI 10.4278/0890-1171-19.2.128
   Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276
   Fleischhacker SE, 2011, OBES REV, V12, Pe460, DOI 10.1111/j.1467-789X.2010.00715.x
   Ford PB, 2008, NUTR REV, V66, P216, DOI 10.1111/j.1753-4887.2008.00026.x
   Frank L, 2009, BRIT J SPORT MED, V43, P124, DOI 10.1136/bjsm.2008.055533
   Frank L, 2020, CAN J PUBLIC HEALTH, V0, P0
   Frank L, 2008, TRANSPORTATION, V35, P37, DOI 10.1007/s11116-007-9136-6
   Frank LD, 2006, J AM PLANN ASSOC, V72, P75, DOI 10.1080/01944360608976725
   Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011
   Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001
   Frank LD, 2007, BERKELEY PLANNING J, V19, P31
   Galvez MP, 2008, PUBLIC HEALTH NUTR, V11, P624, DOI 10.1017/S1368980007001097
   Gebel K, 2007, AM J PREV MED, V32, P361, DOI 10.1016/j.amepre.2007.01.020
   Giskes K, 2007, PUBLIC HEALTH NUTR, V10, P1005, DOI 10.1017/S1368980007665525
   Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330
   Glanz K, 2007, AM J PREV MED, V32, P282, DOI 10.1016/j.amepre.2006.12.019
   Hannes Els, 2009, ENV BEHAV, V41, P0
   Heath Gregory W, 2006, J PHYS ACT HEALTH, V3, PS55, DOI 10.1123/jpah.3.s1.s55
   Jago R, 2006, AM J HEALTH PROMOT, V20, P422, DOI 10.4278/0890-1171-20.6.422
   James WPT, 2008, OBES REV, V9, P6, DOI 10.1111/j.1467-789X.2007.00432.x
   Kelly B, 2011, HEALTH PLACE, V17, P1284, DOI 10.1016/j.healthplace.2011.08.014
   Liese AD, 2007, J AM DIET ASSOC, V107, P1916, DOI 10.1016/j.jada.2007.08.012
   Matthews SA, 2008, AM J PREV MED, V34, P257, DOI 10.1016/j.amepre.2007.12.001
   Moore LV, 2008, AM J EPIDEMIOL, V167, P917, DOI 10.1093/aje/kwm394
   Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040
   Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2
   Pereira CAN, 2010, HEALTH PLACE, V16, P934, DOI 10.1016/j.healthplace.2010.05.007
   Powell LM, 2007, PREV MED, V44, P189, DOI 10.1016/j.ypmed.2006.08.008
   Raja S, 2008, J PLAN EDUC RES, V27, P469, DOI 10.1177/0739456X08317461
   Roemmich JN, 2006, PREV MED, V43, P437, DOI 10.1016/j.ypmed.2006.07.007
   Saelens BE, 2008, MED SCI SPORT EXER, V40, PS550, DOI 10.1249/MSS.0b013e31817c67a4
   Sallis JF, 2006, RES DIGEST, V7, P1
   Sallis JF, 2009, MILBANK Q, V87, P123, DOI 10.1111/j.1468-0009.2009.00550.x
   Sharkey JR, 2008, J NUTR, V138, P620, DOI 10.1093/jn/138.3.620
   Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926
   Timmermans HJP, 2003, J TRANSP GEOGR, V11, P37, DOI 10.1016/S0966-6923(02)00050-9
   Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013
   Wang MC, 2006, INT J BEHAV NUTR PHY, V3, P0, DOI 10.1186/1479-5868-3-15
   Weber CL, 2008, ENVIRON SCI TECHNOL, V42, P3508, DOI 10.1021/es702969f
   Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001
   Zenk SN, 2006, ETHNIC DIS, V16, P275
NR 47
TC 79
Z9 91
U1 0
U2 42
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1479-5868
J9 INT J BEHAV NUTR PHY
JI Int. J. Behav. Nutr. Phys. Act.
PD MAY 20
PY 2012
VL 9
IS 
BP 
EP 
DI 10.1186/1479-5868-9-58
PG 10
WC Nutrition & Dietetics; Physiology
SC Nutrition & Dietetics; Physiology
GA 987CB
UT WOS:000307392900001
PM 22607218
DA 2025-04-28
ER

PT J
AU De Lira-García, C
   Bacardí-Gascón, M
   Jiménez-Cruz, A
AF De Lira-Garcia, Cynthia
   Bacardi-Gascon, Montserrat
   Jimenez-Cruz, Arturo
TI Preferences of healthy and unhealthy foods among 3 to 4 year old children in Mexico
SO ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE food preferences; preschool children; over-weight; obesity; Mexico
ID school-aged children; gender-differences; risk-factors; determinants; obesity
AB Objective: To evaluate the preference of healthy and unhealthy foods among pre-school children attending day-care and its association with that of their parents, body mass index and socio-demographic variables. Methodology: We asked children and parents to depict their food preferences through 54 pictures of different food items. The association between the preferences and socio-demographic variables was done using the Phi correlation, chi-squared, Fisher's correlation, as well as univariate and multivariable logistic regression. Results: Two-hundred and sixty-five parent-child pairs participated in the study. Ice cream, potato chips and lollypops were the foods most preferred by children. On the other hand, quince jelly, coffee and avocado were the least preferred. Overweight and obese children had a higher preference for quince jelly, preserved fruits, and vegetable soup. With univariate logistic regression, children of low-income homes (OR= 2.56, p=0.007) and attending public daycare centers (OR= 6.2, p=0.0001) preferred less healthy fruits. When the father's education was added in a multivariable model including family income, only children whose fathers had <= 9 years of education showed a higher preference for less healthy food. When parent's education, family income, and parent's preference for healthy foods were included to the model only children attending public daycares were more likely to prefer healthy foods. Conclusion: The foods most preferred by children have a high caloric density. The children's body mass index, their parent's monthly income, the father's education and the type of daycare they attended were associated with the preference of healthy or unhealthy foods.
C1 [Bacardi-Gascon, Montserrat] Univ Autonoma Baja California, Sch Med, Fac Psicol & Med, Tijuana Bc 22390, Mexico.
   [De Lira-Garcia, Cynthia] Univ Autonoma Baja California, Escuela Enol & Gastron, Tijuana Bc 22390, Mexico.
C3 Universidad Autonoma de Baja California; Universidad Autonoma de Baja California
RP Bacardí-Gascón, M (corresponding author), Univ Autonoma Baja California, Sch Med, Fac Psicol & Med, Calzada Univ 14418,Parque Ind Int, Tijuana Bc 22390, Mexico.
EM montserrat@uabc.edu.mx
CR Baughcum AE, 2000, PEDIATRICS, V106, P1380, DOI 10.1542/peds.106.6.1380
   Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41
   Caine-Bish NL, 2009, J SCHOOL HEALTH, V79, P532, DOI 10.1111/j.1746-1561.2009.00445.x
   Colapinto CK, 2007, J AM DIET ASSOC, V107, P1183, DOI 10.1016/j.jada.2007.04.012
   Cooke LJ, 2005, BRIT J NUTR, V93, P741, DOI 10.1079/BJN20051389
   Del-Rio-Navarro BE, 2008, ARCH MED RES, V39, P215, DOI 10.1016/j.arcmed.2007.07.008
   Doval HC, 2006, REV ARGENT CARDIOL, V74, P1
   Guthrie CA, 2000, APPETITE, V35, P73, DOI 10.1006/appe.2000.0329
   Hill C, 2009, APPETITE, V52, P603, DOI 10.1016/j.appet.2009.02.003
   Hughes SO, 2007, J DEV BEHAV PEDIATR, V28, P100, DOI 10.1097/01.DBP.0000267561.34199.a9
   Jaramillo SJ, 2006, J NUTR EDUC BEHAV, V38, P352, DOI 10.1016/j.jneb.2006.06.003
   Jimenez Cruz A, 2010, CHILD PSYCHIAT HUMAN, V41, P490
   Jimenez-Cruz A, 2010, ASIA PAC J CLIN NUTR, V19, P316
   Johannsen DL, 2006, OBESITY, V14, P431, DOI 10.1038/oby.2006.57
   KLESGES RC, 1983, J APPL BEHAV ANAL, V16, P371, DOI 10.1901/jaba.1983.16-371
   López-Alvarenga JC, 2007, GAC MED MEX, V143, P463
   MELA DJ, 1991, AM J CLIN NUTR, V53, P908, DOI 10.1093/ajcn/53.4.908
   Nicklaus S, 2004, FOOD QUAL PREFER, V15, P805, DOI 10.1016/j.foodqual.2004.02.010
   Perichart-Perera O, 2007, J AM DIET ASSOC, V107, P81, DOI 10.1016/j.jada.2006.10.011
   Ramírez-Ley K, 2009, J PUBLIC HEALTH-UK, V31, P383, DOI 10.1093/pubmed/fdp058
   Ricketts CD, 1997, EUR J CLIN NUTR, V51, P778, DOI 10.1038/sj.ejcn.1600487
   Romero-Velarde E, 2007, SALUD PUBLICA MEXICO, V49, P103, DOI 10.1590/S0036-36342007000200005
   Skinner J, 1998, J NUTR EDUC, V30, P17, DOI 10.1016/S0022-3182(98)70270-5
   Skinner JD, 2002, J AM DIET ASSOC, V102, P1638, DOI 10.1016/S0002-8223(02)90349-4
   Unusan N, 2006, FOOD QUAL PREFER, V17, P362, DOI 10.1016/j.foodqual.2005.04.008
   Wardle J, 2001, APPETITE, V37, P217, DOI 10.1006/appe.2001.0423
   Wardle J, 2001, INT J OBESITY, V25, P971, DOI 10.1038/sj.ijo.0801661
   Wardle J, 2008, BRIT J NUTR, V99, PS15, DOI 10.1017/S000711450889246X
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA, V0, P0
NR 29
TC 6
Z9 8
U1 0
U2 16
PU H E C PRESS, HEALTHY EATING CLUB PTY LTD
PI MCKINNON
PA PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA
SN 0964-7058
EI 1440-6047
J9 ASIA PAC J CLIN NUTR
JI Asia Pac. J. Clin. Nutr.
PD JUN 15
PY 2012
VL 21
IS 1
BP 57
EP 63
DI 
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 907ER
UT WOS:000301401100008
PM 22374561
DA 2025-04-28
ER

PT J
AU Schmitt, GC
   Arbo, MD
   Lorensi, AL
   Maciel, ES
   Krahn, CL
   Mariotti, KC
   Dallegrave, E
   Leal, MB
   Limberger, RP
AF Schmitt, Gabriela C.
   Arbo, Marcelo D.
   Lorensi, Andreia L.
   Maciel, Erica S.
   Krahn, Carolina L.
   Mariotti, Kristiane C.
   Dallegrave, Eliane
   Leal, Mirna B.
   Limberger, Renata P.
TI Toxicological Effects of a Mixture Used in Weight Loss Products: p-Synephrine Associated With Ephedrine, Salicin, and Caffeine
SO INTERNATIONAL JOURNAL OF TOXICOLOGY
LA English
DT Article
DE p-synephrine; ephedrine; salicin; caffeine; weight loss; acute toxicity
ID central-nervous-system; aurantium l. rutaceae; citrus-aurantium; acute toxicity; dietary-supplements; body-temperature; bitter orange; extract; overweight; alkaloids
AB p-Synephrine is an adrenergic amine found in Citrus aurantium L. fruits and has been used for weight loss in dietary supplements. There are commercial products containing this substance associated to caffeine, salicin, and ephedrine. The aim of this study was to evaluate the acute toxicity of this mixture in mice of both sexes. The significative results observed after acute oral administration to male and female mice of 300, 350, and 400 mg/kg total of p-synephrine, ephedrine, salicin, plus caffeine in a 10:4:6:80 w/w ratio included a reduction in locomotor activity and ptosis in all treated groups for both sexes. Seizures were also observed in male (400 mg/kg) and female groups (350 and 400 mg/kg). Gasping and tearing were observed in males. Salivation (400 mg/kg), agitation (350 and 400 mg/kg), and piloerection (all treated groups) were significantly observed only in females. Deaths occurred in males at 350 and 400 mg/kg treated groups and the necropsy showed cardiopulmonary hemorrhage. A reduction in locomotor activity was confirmed through the spontaneous locomotor activity test, in which the number of crossings considerably decreased (P < .01) in all treated groups. The rotarod test showed a decrease in motor coordination at 400 mg/kg. Body temperature decreased significantly (P < .01) in all treated groups compared to controls. The results suggested clear signs of toxicity of p-synephrine, ephedrine, salicin, and caffeine association; this toxicity augments the attentiveness on commercial products containing this mixture, given the expressive number of adverse events related to its utilization.
C1 [Schmitt, Gabriela C.; Arbo, Marcelo D.; Krahn, Carolina L.; Mariotti, Kristiane C.; Limberger, Renata P.] Univ Fed Rio Grande do Sul, Dept Anal, Fac Pharm, BR-90610000 Porto Alegre, RS, Brazil.
   [Lorensi, Andreia L.; Maciel, Erica S.; Leal, Mirna B.] Univ Fed Rio Grande do Sul, Dept Pharmacol, Inst Basic Hlth Sci, BR-90610000 Porto Alegre, RS, Brazil.
   [Dallegrave, Eliane] Fundacao Estadual Prod & Pesquisa Saude, Toxicol Informat Ctr Rio Grande Sul, Porto Alegre, RS, Brazil.
C3 Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul
RP Limberger, RP (corresponding author), Univ Fed Rio Grande do Sul, Dept Anal, Fac Pharm, Av Ipiranga 2752-605, BR-90610000 Porto Alegre, RS, Brazil.
EM rlrenata@yahoo.com
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
CR Almeida RN, 2006, PSICOFARMACOLOGIA FU, V0, P134
   Arbo MD, 2008, FOOD CHEM TOXICOL, V46, P2770, DOI 10.1016/j.fct.2008.04.037
   Arbo MD, 2009, REGUL TOXICOL PHARM, V54, P114, DOI 10.1016/j.yrtph.2009.03.001
   Arbo MD, 2009, ARCH TOXICOL, V83, P95, DOI 10.1007/s00204-008-0324-8
   Bouchard NC, 2005, MAYO CLIN PROC, V80, P541, DOI 10.4065/80.4.541
   Bristow LJ, 1996, J PHARMACOL EXP THER, V277, P578
   Bui LT, 2006, ANN PHARMACOTHER, V40, P53, DOI 10.1345/aph.1G488
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Consoli D, 2007, EUR J PHARMACOL, V573, P139, DOI 10.1016/j.ejphar.2007.06.048
   Cordioli A V, 2005, PSICOFARMACOS - CONSULTA RAPIDA, V0, P0
   CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854
   DALLMEIER K, 1981, PHARMACOLOGY, V22, P113, DOI 10.1159/000137479
   Dluzen DE, 2002, NEUROTOXICOL TERATOL, V24, P267, DOI 10.1016/S0892-0362(02)00187-3
   Firenzuoli F, 2005, PHYTOMEDICINE, V12, P247, DOI 10.1016/j.phymed.2004.02.005
   Fonsart J, 2008, TOXICOL APPL PHARM, V230, P117, DOI 10.1016/j.taap.2008.02.004
   Franco CIF, 2005, J ETHNOPHARMACOL, V98, P275, DOI 10.1016/j.jep.2005.01.008
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   Gad SC, 2003, INT J TOXICOL, V22, P381, DOI 10.1080/713936674
   Gange CA, 2006, MAYO CLIN PROC, V81, P545, DOI 10.4065/81.4.545
   GOLDIM JR, 1995, PESQUISA SAUDE DIREI, V0, P0
   Haaz S, 2006, OBES REV, V7, P79, DOI 10.1111/j.1467-789X.2006.00195.x
   Haller CA, 2005, AM J MED, V118, P998, DOI 10.1016/j.amjmed.2005.02.034
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Haller CA, 2004, CLIN PHARMACOL THER, V75, P259, DOI 10.1016/j.clpt.2003.11.375
   Haller CA, 2008, BRIT J CLIN PHARMACO, V65, P833, DOI 10.1111/j.1365-2125.2008.03144.x
   HORTON TJ, 1991, INT J OBESITY, V15, P359
   Jordan Scott, 2004, CMAJ, V171, P993
   Kalman D, 2002, INT J OBESITY, V26, P1363, DOI 10.1038/sj.ijo.0802061
   Kim KW, 2001, N-S ARCH PHARMACOL, V364, P21, DOI 10.1007/s002100100416
   Linck VD, 2009, PHYTOMEDICINE, V16, P303, DOI 10.1016/j.phymed.2008.08.001
   Marcus DM, 2003, SCIENCE, V301, P1669
   Mattei R, 1995, ARCH INT PHARMACOD T, V330, P279
   Nasir JM, 2004, MAYO CLIN PROC, V79, P1059, DOI 10.4065/79.8.1059
   Nykamp DL, 2004, ANN PHARMACOTHER, V38, P812, DOI 10.1345/aph.1D473
   Okuro M, 2010, SLEEP, V33, P930, DOI 10.1093/sleep/33.7.930
   Olfert ED, 1998, MANUAL SOBRE CUIDADO, V0, P0
   Ozturk Y, 1996, PHYTOMEDICINE, V3, P139, DOI 10.1016/S0944-7113(96)80027-4
   Pechlivanova D, 2010, BEHAV BRAIN RES, V209, P205, DOI 10.1016/j.bbr.2010.01.037
   Pellati F, 2005, J PHARMACEUT BIOMED, V37, P839, DOI 10.1016/j.jpba.2004.09.008
   Pellati F, 2007, J CHROMATOGR A, V1161, P71, DOI 10.1016/j.chroma.2007.05.097
   Preuss HG, 2002, J MED, V33, P1
   Rang HP, 2007, RANG DALE FARMACOLOGIA, V0, P0
   Rossato LG, 2011, ARCH TOXICOL, V85, P929, DOI 10.1007/s00204-010-0630-9
   Rossato LG, 2011, FOOD CHEM TOXICOL, V49, P8, DOI 10.1016/j.fct.2010.11.007
   Samenuk D, 2002, MAYO CLIN PROC, V77, P12, DOI 10.4065/77.1.12
   Schaneberg BT, 2003, PHYTOCHEMISTRY, V62, P911, DOI 10.1016/S0031-9422(02)00716-1
   Schaneberg BT, 2004, PHARMAZIE, V59, P819
   Stone EA, 2007, BIOCHEM PHARMACOL, V73, P1063, DOI 10.1016/j.bcp.2006.10.001
   Watanabe M, 2008, IMMUNOL LETT, V115, P43, DOI 10.1016/j.imlet.2007.09.010
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
NR 52
TC 17
Z9 17
U1 1
U2 31
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1091-5818
EI 1092-874X
J9 INT J TOXICOL
JI Int. J. Toxicol.
PD MAR-APR 15
PY 2012
VL 31
IS 2
BP 184
EP 191
DI 10.1177/1091581811435708
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 920UR
UT WOS:000302434100007
PM 22408069
DA 2025-04-28
ER

PT J
AU Kim, HJ
   Ko, J
   Storni, C
   Song, HJ
   Cho, YG
AF Kim, Hwa Jung
   Ko, Jeongah
   Storni, Charlotte
   Song, Hong Ji
   Cho, Young Gyu
TI Effect of green mate in overweight volunteers: A randomized placebo-controlled human study
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Mate; Ilex paraguariensis A. St.-Hil.; Obesity; Weight loss; Clinical study; Anti-obesity
ID ilex-paraguariensis; weight-loss; dietary-supplements; aqueous extract; body-weight; obesity; tea; inhibition; saponins; caffeine
AB Overweight and obesity have become a global epidemic and they may impair health. Traditional use and growing evidence indicate that mate (Ilex paraguariensis A. St.-Hil.) may be helpful in losing excessive weight and fat. The present randomized, double-blind, placebo-controlled study evaluated efficacy and safety of an extract from green mate in 60 overweight subjects aged 20-39 years during 6-weeks. Body composition was measured by Dual-Energy X-ray Absorptiometry (DEXA) at baseline and after 6 weeks. Body weight, body mass index (BMI), waist circumference (WC) and various safety parameters were monitored. After 6 weeks, subjects taking mate experienced a significantly greater reduction of percent of body fat (-0.3% vs. +0.6%, p = 0.04) and fat mass (-0.5 kg vs. +0.2 kg, p = 0.04) than placebo. No significant differences were observed in other measurements. No adverse events occurred and all safety parameters were within normal ranges during the study in both groups. Thus, taking green mate extract reduced body fat after 6 weeks, while the treatment was safe and well tolerated. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Storni, Charlotte] Frutarom Switzerland Ltd, CH-8820 Wadenswil, Switzerland.
   [Kim, Hwa Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul 138736, South Korea.
   [Ko, Jeongah] Korea Olymp Comm, Korea Natl Training Ctr, Seoul 139804, South Korea.
   [Song, Hong Ji] Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Family Med, Anyang Si 431070, Gyeonggi Do, South Korea.
   [Cho, Young Gyu] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Family Med, Seoul 100032, South Korea.
C3 University of Ulsan; Asan Medical Center; Hallym University; Inje University
RP Storni, C (corresponding author), Frutarom Switzerland Ltd, Rutiwisstr 7, CH-8820 Wadenswil, Switzerland.
EM rsvp@amc.seoul.kr; nanadoc@naver.com; cstorni@ch.frutarom.com; hongjisong5@gmail.com; jacobel@hanmail.net
FU Frutarom Switzerland Ltd.
CR ALIKARIDIS F, 1987, J ETHNOPHARMACOL, V20, P121, DOI 10.1016/0378-8741(87)90084-5
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Arçari DP, 2011, J FUNCT FOODS, V3, P190, DOI 10.1016/j.jff.2011.04.001
   Aucott LS, 2008, P NUTR SOC, V67, P54, DOI 10.1017/S0029665108006022
   Ayyad C, 2000, OBES REV, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x
   Berté KAS, 2011, J AGR FOOD CHEM, V59, P5523, DOI 10.1021/jf2008343
   CZOK G, 1961, ARZNEIMITTEL-FORSCH, V11, P545
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Filip R, 2003, EUR J NUTR, V42, P50, DOI 10.1007/s00394-003-0399-1
   Flint AJ, 2010, OBESITY, V18, P377, DOI 10.1038/oby.2009.223
   Fontaine K R, 2001, EAT BEHAV, V2, P87, DOI 10.1016/S1471-0153(01)00024-1
   GRACZA L, 1987, ARCH PHARM, V320, P1249, DOI 10.1002/ardp.198700042
   GREENWAY FL, 2004, HDB OBESITY, V0, P329
   GUGLIUCCI A, 1995, BIOCHEM MOL BIOL INT, V35, P47
   Gugliucci A, 1996, BIOCHEM BIOPH RES CO, V224, P338, DOI 10.1006/bbrc.1996.1030
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   Han UK, 2002, J NUTR, V132, P2241, DOI 10.1093/jn/132.8.2241
   Heck CI, 2007, YERBA MATE TEA ILEX, V72, P0
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Kurth T, 2002, ARCH INTERN MED, V162, P2557, DOI 10.1001/archinte.162.22.2557
   Martinet A, 1999, PHYTOMEDICINE, V6, P231, DOI 10.1016/S0944-7113(99)80014-2
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022
   Opala T, 2006, EUR J MED RES, V11, P343
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136
   Pittler MH, 2005, OBES REV, V6, P93, DOI 10.1111/j.1467-789X.2005.00169.x
   Poston WSC, 2001, OBES RES, V9, P552, DOI 10.1038/oby.2001.72
   Schinella GR, 2000, BIOCHEM BIOPH RES CO, V269, P357, DOI 10.1006/bbrc.2000.2293
   Seeram NP, 2006, J AGR FOOD CHEM, V54, P1599, DOI 10.1021/jf052857r
   Stein FLP, 2005, BIOL RES NURS, V7, P146, DOI 10.1177/1099800405280521
   Xu BJ, 2005, ARCH PHARM RES, V28, P180, DOI 10.1007/BF02977712
   Zhao HL, 2005, INT J OBESITY, V29, P983, DOI 10.1038/sj.ijo.0802948
NR 34
TC 24
Z9 29
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN 15
PY 2012
VL 4
IS 1
BP 287
EP 293
DI 10.1016/j.jff.2011.12.005
PG 7
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 913NN
UT WOS:000301884800032
DA 2025-04-28
ER

PT J
AU Shaneshin, M
   Rashidkhani, B
   Rabiei, S
AF Shaneshin, Mahboubeh
   Rashidkhani, Bahram
   Rabiei, Samira
TI Accuracy of Energy Intake Reporting: Comparison of Energy Intake and Resting Metabolic Rate and their Relation to Anthropometric and Sociodemographic Factors among Iranian Women
SO ARCHIVES OF IRANIAN MEDICINE
LA English
DT Article
DE Anthropometric characteristics; energy intake; energy reporting; resting metabolism; sociodemographic factors
ID food-intake; dietary patterns; weight status; affluent society; body-weight; life-style; obese; expenditure; recall; adults
AB Background: This study assesses the accuracy of energy intake (El) reporting and its relation to anthropometric characteristics and sociodemographic factors. In addition, we attempt to identify foods for which under- or over-reporting is more prevalent. Methods: El was assessed for 187 women using a semi-quantitative 168-item food frequency questionnaire (FFQ). Resting metabolic rate (RMR) was measured with an indirect calorimeter. We calculated the El/RMR ratio to assess the accuracy of El reporting. This study defined under-reporters as those with an El/RMR of <= 1.34 and over-reporters as those with an El/RMR of >= 2.4. We measured anthropometric characteristics and collected sociodemographic information. The chi-square test, ANOVA and multiple linear regressions were used for statistical analyses. Results: Among participants, the under-reporting rate was 35.5% and the over-reporting rate was 7.5%. The El/RMR ratio was significantly higher for younger women compared to older women (P < 0.04). Under-reporters had higher weight, waist circumference (WC), body mass index (BMI) and resting metabolism compared to accurate reporters (P < 0.05). Resting metabolism was significantly lower among over-reporters than accurate reporters. After adjusting for energy, the consumption of fish, high-fat dairy products, hydrogenated oil, sweets and coffee was lower, whereas consumption of unsaturated oils, tea, salt and yellow vegetables was higher among under-reporters compared to accurate reporters. Conclusion: Under-reporting of El is more frequent than over-reporting among Iranian women. Among various factors that may affect the accuracy of El reporting, age and anthropometric characteristics might have a significant effect.
C1 [Shaneshin, Mahboubeh; Rashidkhani, Bahram; Rabiei, Samira] Shahid Beheshti Univ Med Sci & Hlth Serv, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Community Nutr Dept, Tehran, Iran.
C3 Shahid Beheshti University Medical Sciences
RP Rashidkhani, B (corresponding author), Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, Tehran, Iran.
EM b_rashidkhani@sbmu.ac.ir
FU National Nutrition and Food Technology Research Institute of Shahid Beheshti University of Medical Sciences
CR Asbeck I, 2002, PUBLIC HEALTH NUTR, V5, P683, DOI 10.1079/PHN2002337
   Bailey RL, 2007, J AM DIET ASSOC, V107, P64, DOI 10.1016/j.jada.2006.10.009
   BallardBarbash R, 1996, EUR J CLIN NUTR, V50, P98
   Bedard D, 2004, PUBLIC HEALTH NUTR, V7, P675, DOI 10.1079/PHN2003578
   Berg CM, 2008, AM J CLIN NUTR, V88, P289
   BLACK AE, 1991, EUR J CLIN NUTR, V45, P583
   Black AE, 1997, EUR J CLIN NUTR, V51, P405, DOI 10.1038/sj.ejcn.1600425
   Black AE, 1996, EUR J CLIN NUTR, V50, P72
   Briefel RR, 1997, AM J CLIN NUTR, V65, P1203
   Delisle HF, 2009, NUTR J, V8, P0, DOI 10.1186/1475-2891-8-3
   DEVRIES JHM, 1994, AM J CLIN NUTR, V60, P855, DOI 10.1093/ajcn/60.6.855
   Drummond SE, 1998, INT J OBESITY, V22, P105, DOI 10.1038/sj.ijo.0800552
   Energy WHO, 1985, WHO TECHN REP SER, V724, P0
   Esmaillzadeh A, 2008, J NUTR, V138, P358, DOI 10.1093/jn/138.2.358
   Forman JN, 1998, INT J OBESITY, V22, P215, DOI 10.1038/sj.ijo.0800569
   Ghaffarpour M, 1999, TEHRAN NASHRE OLUME, V7, P42
   Goris AHC, 2000, AM J CLIN NUTR, V71, P130
   Harrison GG, 2000, J NUTR, V130, P2049, DOI 10.1093/jn/130.8.2049
   HEITMANN BL, 1995, BRIT MED J, V311, P986
   Johansson G, 2001, PUBLIC HEALTH NUTR, V4, P919, DOI 10.1079/PHN2001124
   Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266
   Johnson RK, 1998, J AM DIET ASSOC, V98, P1136, DOI 10.1016/S0002-8223(98)00263-6
   Lafay L, 2000, INT J OBESITY, V24, P1500, DOI 10.1038/sj.ijo.0801392
   LISSNER L, 1989, AM J CLIN NUTR, V49, P320, DOI 10.1093/ajcn/49.2.320
   Livingstone MBE, 2003, J NUTR, V133, P895S, DOI 10.1093/jn/133.3.895S
   LIVINGSTONE MBE, 1995, BRIT J BIOMED SCI, V52, P58
   Mendez MA, 2004, PUBLIC HEALTH NUTR, V7, P9, DOI 10.1079/PHN2003508
   Mirmiran P, 2006, ASIA PAC J CLIN NUTR, V15, P459
   Novotny J, 2003, J AM DIET ASSOC, V103, P1146, DOI 10.1016/S0002-8223(03)00975-1
   Okubo H, 2006, PUBLIC HEALTH NUTR, V9, P651, DOI 10.1079/PHN2005894
   Poppitt SD, 1998, INT J OBESITY, V22, P303, DOI 10.1038/sj.ijo.0800584
   Prentice AM, 1996, EUR J CLIN NUTR, V50, P93
   Rezazadeh A, 2010, NUTRITION, V26, P337, DOI 10.1016/j.nut.2009.06.019
   Samaras K, 1999, INT J OBESITY, V23, P881, DOI 10.1038/sj.ijo.0800967
   Scagliusi FB, 2008, BRIT J NUTR, V100, P1060, DOI 10.1017/S0007114508971300
   Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379
   Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607
   Willett WC, 1998, NUTR EPIDEMIOLOGY, V0, P0
NR 40
TC 8
Z9 8
U1 0
U2 9
PU ACAD MEDICAL SCIENCES I R IRAN
PI TEHRAN
PA PO BOX 19395-5655, TEHRAN, 00000, IRAN
SN 1029-2977
EI 1735-3947
J9 ARCH IRAN MED
JI Arch. Iran. Med.
PD NOV 15
PY 2012
VL 15
IS 11
BP 681
EP 687
DI 
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 049EQ
UT WOS:000311965400005
PM 23102244
DA 2025-04-28
ER

PT J
AU Gunes, FE
   Bekiroglu, N
   Imeryuz, N
   Agirbasli, M
AF Gunes, Fatma Esra
   Bekiroglu, Nural
   Imeryuz, Nese
   Agirbasli, Mehmet
TI Relation between Eating Habits and a High Body Mass Index among Freshman Students: A Cross-Sectional Study
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE eating habits; body mass index; freshman students; obesity; overweight
ID fast-food consumption; university-students; college-students; energy-intake; life-style; snacking patterns; medical-students; dietary habits; weight status; obesity risk
AB Objectives: This study aimed to examine the relation between eating habits and a high body mass index (BMI) in first-year freshman university students and included 2525 freshman university students 18 to 22 years old from a Turkish population. Methods: in this study, 48% of the students were men. They were asked to complete a questionnaire on their dietary habits including the frequency of their consumption of individual food items, demographic data, and smoking habit. Results: The effects of eating habits on increased BMI (>= 25) were analyzed. Of 2259 subjects included in the analyses, 322 were overweight or obese and 1937 had normal and thin BMI (<25). Multivariate analyses identified male gender, recent weight change, and high number of meals as independent predictors of obesity/overweight. Frequent consumptions of beer, alcoholic drinks other than beer and wine (e.g., spirits including whisky, gin, raid, vodka), coffee, tea, coke, red meat, variety meat, and eggs were associated with a significantly higher risk of obesity/overweight, whereas frequent consumption of snacks was associated with a low risk. Conclusions: Findings of further studies, possibly taking into consideration the absolute quantities of consumption along with cultural and local issues, would guide the adoption of healthier feeding behaviors in this particular age group.
C1 [Gunes, Fatma Esra] Marmara Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-34000 Istanbul, Turkey.
   [Bekiroglu, Nural] Marmara Univ, Sch Med, Dept Biostat, TR-34000 Istanbul, Turkey.
   [Imeryuz, Nese] Marmara Univ, Sch Med, Dept Gastroenterol, TR-34000 Istanbul, Turkey.
   [Agirbasli, Mehmet] Marmara Univ, Sch Med, Dept Cardiol, TR-34000 Istanbul, Turkey.
C3 Marmara University; Marmara University; Marmara University; Marmara University
RP Gunes, FE (corresponding author), Marmara Univ, Fac Hlth Sci, Dept Nutr & Dietet, E-5 Uzeri Yanyol, TR-34000 Istanbul, Turkey.
EM fegunes@marmara.edu.tr
CR Adlaf EM, 2001, J AM COLL HEALTH, V50, P67, DOI 10.1080/07448480109596009
   Al-Rethaiaa AS, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-39
   Ayranci U, 2010, NUTRITION, V26, P772, DOI 10.1016/j.nut.2009.07.007
   Bagriacik N, 2009, INT J DIABETESMETABOLISM, V17, P5
   Baric IC, 2003, INT J FOOD SCI NUTR, V54, P473, DOI 10.1080/09637480310001622332
   Bellisle F, 1997, BRIT J NUTR, V77, PS57, DOI 10.1079/BJN19970104
   Bertéus-Forslund H, 2005, INT J OBESITY, V29, P711, DOI 10.1038/sj.ijo.0802950
   Boo NY, 2010, SINGAP MED J, V51, P126
   Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Brunt AR, 2008, APPETITE, V51, P615, DOI 10.1016/j.appet.2008.04.019
   Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   Chourdakis M, 2010, APPETITE, V55, P722, DOI 10.1016/j.appet.2010.08.013
   de Graaf C, 2006, APPETITE, V47, P18, DOI 10.1016/j.appet.2006.02.007
   Dinger MK, 1997, AM J HEALTH PROMOT, V11, P360, DOI 10.4278/0890-1171-11.5.360
   Duffrin C, 2010, INTERNET J NUTR WELL, V10, P0
   Farshchi HR, 2004, INT J OBESITY, V28, P653, DOI 10.1038/sj.ijo.0802616
   GLORE SR, 1993, J AM COLL NUTR, V12, P517, DOI 10.1080/07315724.1993.10718345
   Gow RW, 2010, EAT BEHAV, V11, P33, DOI 10.1016/j.eatbeh.2009.08.005
   Gyntelberg F, 2009, INT J FOOD SCI NUTR, V60, P56, DOI 10.1080/09637480802668471
   Hajhosseini L, 2006, J AM COLL NUTR, V25, P123, DOI 10.1080/07315724.2006.10719522
   Hampl JS, 2003, J HUM NUTR DIET, V16, P3, DOI 10.1046/j.1365-277X.2003.00417.x
   Hoffman DJ, 2006, J AM COLL HEALTH, V55, P41, DOI 10.3200/JACH.55.1.41-46
   Hosmer W, 2000, APPLIED LOGISTIC REGRESSION, VSecond, P0
   Kirk TR, 2000, P NUTR SOC, V59, P349, DOI 10.1017/S0029665100000409
   Larson NI, 2007, PREV CHRONIC DIS, V4, P0
   Lukasiewicz E, 2005, PUBLIC HEALTH NUTR, V8, P315, DOI 10.1079/PHN2004680
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malinauskas BM, 2006, NUTR J, V5, P0, DOI 10.1186/1475-2891-5-11
   Marmonier C, 1999, AM J CLIN NUTR, V70, P854
   Mihas C, 2010, PUBLIC HEALTH NUTR, V13, P712, DOI 10.1017/S1368980009991625
   Papadaki A, 2007, APPETITE, V49, P169, DOI 10.1016/j.appet.2007.01.008
   Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x
   Sakamaki R, 2005, NUTR J, V4, P0, DOI 10.1186/1475-2891-4-4
   Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.1551
   Singhal N, 2010, EUR J CLIN NUTR, V64, P364, DOI 10.1038/ejcn.2009.150
   Spanos D, 2010, J HUM NUTR DIET, V23, P102, DOI 10.1111/j.1365-277X.2009.01005.x
   Suleiman AA, 2009, JOURNAL OF BIOLOGICAL SCIENCES, V9, P738
   Taveras EM, 2005, PEDIATRICS, V116, PE518, DOI 10.1542/peds.2004-2732
   Taylor CB, 1998, INT J EAT DISORDER, V24, P31, DOI 10.1002/(SICI)1098-108X(199807)24:1<31::AID-EAT3>3.0.CO;2-1
   Vik FN, 2010, SCAND J PUBLIC HEALT, V38, P13, DOI 10.1177/1403494810378920
   Wang Y, 2009, INT J OBESITY, V33, P621, DOI 10.1038/ijo.2009.45
   Yahia N, 2008, NUTR J, V7, P0, DOI 10.1186/1475-2891-7-32
   Zemel MB, 2005, OBES RES, V13, P192, DOI 10.1038/oby.2005.26
NR 45
TC 26
Z9 28
U1 1
U2 44
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD JUN 15
PY 2012
VL 31
IS 3
BP 167
EP 174
DI 10.1080/07315724.2012.10720024
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 069XN
UT WOS:000313470500005
PM 23204153
DA 2025-04-28
ER

PT J
AU Panchal, SK
   Poudyal, H
   Waanders, J
   Brown, L
AF Panchal, Sunil K.
   Poudyal, Hemant
   Waanders, Jennifer
   Brown, Lindsay
TI Coffee Extract Attenuates Changes in Cardiovascular and Hepatic Structure and Function without Decreasing Obesity in High-Carbohydrate, High-Fat Diet-Fed Male Rats
SO JOURNAL OF NUTRITION
LA English
DT Article
ID metabolic syndrome; endothelial function; abdominal obesity; chlorogenic acid; blood-pressure; risk; consumption; caffeine; disease; healthy
AB Coffee, a rich source of natural products, including caffeine, chlorogenic acid, and diterpenoid alcohols, has been part of the human diet since the 15th century. In this study, we characterized the effects of Colombian coffee extract (CE), which contains high concentrations of caffeine and diterpenoids, on a rat model of human metabolic syndrome. The 8-9 wk old male Wistar rats were divided into four groups. Two groups of rats were fed a corn starch-rich diet whereas the other two groups were given a high-carbohydrate, high-fat diet with 25% fructose in drinking water for 16 wk. One group fed each diet was supplemented with 5% aqueous CE for the final 8 wk of this protocol. The corn starch diet contained similar to 68% carbohydrates mainly as polysaccharides, whereas the high-carbohydrate, high-fat diet contained similar to 68% carbohydrates mainly as fructose and sucrose together with 24% fat, mainly as saturated and monounsaturated fat from beef tallow. The high-carbohydrate, high-fat diet-fed rats showed the symptoms of metabolic syndrome leading to cardiovascular remodeling and nonalcoholic fatty liver disease. CE supplementation attenuated impairment in glucose tolerance, hypertension, cardiovascular remodeling, and nonalcoholic fatty liver disease without changing abdominal obesity and dyslipidemia. This study suggests that CE can attenuate diet-induced changes in the structure and function of the heart and the liver without changing the abdominal fat deposition. J. Nutr. 142: 690-697, 2012.
C1 [Panchal, Sunil K.; Brown, Lindsay] Univ So Queensland, Dept Biol & Phys Sci, Toowoomba, Qld 4350, Australia.
   [Panchal, Sunil K.; Poudyal, Hemant; Brown, Lindsay] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.
   [Waanders, Jennifer] Univ Queensland, Sch Land Crop & Food Sci, Brisbane, Qld, Australia.
C3 University of Southern Queensland; University of Queensland; University of Queensland
RP Brown, L (corresponding author), Univ So Queensland, Dept Biol & Phys Sci, Toowoomba, Qld 4350, Australia.
EM Lindsay.Brown@usq.edu.au
FU Dr. Red Nutraceuticals, Brisbane, Australia; Prince Charles Hospital Foundation, Brisbane, Australia
CR ARO A, 1987, METABOLISM, V36, P1027, DOI 10.1016/0026-0495(87)90021-7
   Bachmann K, 1996, ENVIRON HEALTH PERSP, V104, P400, DOI 10.2307/3432684
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Bhattacharya J, 2011, J ECON PERSPECT, V25, P139, DOI 10.1257/jep.25.1.139
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Buscemi S, 2010, EUR J CLIN NUTR, V64, P483, DOI 10.1038/ejcn.2010.9
   Casanueva FF, 2010, CLIN ENDOCRINOL, V73, P35, DOI 10.1111/j.1365-2265.2009.03727.x
   Catalano D, 2010, DIGEST DIS SCI, V55, P3200, DOI 10.1007/s10620-010-1143-3
   de Roos B, 1999, CURR OPIN LIPIDOL, V10, P41, DOI 10.1097/00041433-199902000-00008
   de Roos B, 2001, AM J CLIN NUTR, V73, P45
   DESIMONE G, 1988, JPN HEART J, V29, P151
   Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5
   Duvnjak M, 2007, WORLD J GASTROENTERO, V13, P4539, DOI 10.3748/wjg.v13.i34.4539
   Geleijnse JM, 2008, VASC HEALTH RISK MAN, V4, P963
   Giovannucci E, 1998, AM J EPIDEMIOL, V147, P1043, DOI 10.1093/oxfordjournals.aje.a009398
   Hamer M, 2006, J HUM HYPERTENS, V20, P909, DOI 10.1038/sj.jhh.1002076
   Hu G, 2008, HEPATOLOGY, V48, P129, DOI 10.1002/hep.22320
   Inoue M, 1998, CANCER CAUSE CONTROL, V9, P209, DOI 10.1023/A:1008890529261
   Jakobsen MU, 2007, EPIDEMIOL REV, V29, P77, DOI 10.1093/epirev/mxm002
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kiyohara C, 1999, BRIT J NUTR, V82, P125, DOI 10.1017/S0007114599001270
   Klag MJ, 2002, ARCH INTERN MED, V162, P657, DOI 10.1001/archinte.162.6.657
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188
   Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x
   Nishi M, 1996, JPN J CLIN ONCOL, V26, P42, DOI 10.1093/oxfordjournals.jjco.a023177
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   Panchal SK, 2011, J NUTR, V141, P1062, DOI 10.3945/jn.111.137877
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI 10.1097/FJC.0b013e3181feb90a
   Papamichael CM, 2005, CLIN SCI, V109, P55, DOI 10.1042/CS20040358
   Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011
   Poudyal H, 2010, BRIT J NUTR, V104, P1322, DOI 10.1017/S0007114510002308
   Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18
   SCHWARZ B, 1994, PREV MED, V23, P377, DOI 10.1006/pmed.1994.1052
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4
   Tofovic SP, 2002, KIDNEY INT, V61, P1433, DOI 10.1046/j.1523-1755.2002.00278.x
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   WILSON JR, 1980, AM J MED, V68, P664, DOI 10.1016/0002-9343(80)90252-1
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
NR 47
TC 79
Z9 81
U1 0
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD APR 15
PY 2012
VL 142
IS 4
BP 690
EP 697
DI 10.3945/jn.111.153577
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 914RT
UT WOS:000301970200008
PM 22378327
DA 2025-04-28
ER

PT J
AU Chellan, N
   Muller, CJF
   de Beer, D
   Joubert, E
   Page, BJ
   Louw, J
AF Chellan, N.
   Muller, C. J. F.
   de Beer, D.
   Joubert, E.
   Page, B. J.
   Louw, J.
TI An in vitro assessment of the effect of Athrixia phylicoides DC. aqueous extract on glucose metabolism
SO PHYTOMEDICINE
LA English
DT Article
DE Athrixia phylicoides; Diabetes; Glucose metabolism; Bush tea; Polyphenols
ID insulin-resistance; antioxidant activity; diabetes-mellitus; south-africa; beta-cells; flavonoids; acid; mice; polyphenols; homeostasis
AB Athrixia phylicoides DC. is an aromatic shrub indigenous to the eastern parts of Southern Africa. Indigenous communities brew "bush tea" from dried twigs and leaves of A. phylicoides, which is consumed as a beverage and used for its medicinal properties. Plant polyphenols have been shown to be beneficial to Type 2 diabetes mellitus (T2D) and obesity. Aqueous extracts of the plant have been shown to be rich in polyphenols, in particular phenolic acids, which may enhance glucose uptake and metabolism. The aim of this study was to determine the phenolic composition of a hot water A. phylicoides extract and assess its in vitro effect on cellular glucose utilisation. The most abundant phenolic compounds in the extract were 6-hydroxyluteolin-7-O-glucoside, chlorogenic acid, protocatechuic acid, a di-caffeoylquinic acid and a methoxy-flavonol derivative. The extract increased glucose uptake in C2C12, Chang and 3T3-L1 cells, respectively. Intracellular glucose was utilised by both oxidation (C2C12 myocytes and Chang cells; p < 0.01 and p < 0.05, respectively) and by increased glycogen storage (Chang cells; p < 0.05). No cytotoxicity was observed in Chang cells at the concentrations tested. The effects of the extract were not dose-dependent. A. phylicoides aqueous extract stimulated in vitro glucose uptake and metabolism, suggesting that consumption of this phenolic-rich extract could potentially ameliorate metabolic disorders related to obesity and T2D. (C) 2012 Elsevier GmbH. All rights reserved.
C1 [Chellan, N.; Muller, C. J. F.; Louw, J.] MRC, ZA-7505 Tygerberg, South Africa.
   [de Beer, D.; Joubert, E.] Agr Res Council ARC Infruitec Nietvoorbij, Postharvest & Wine Technol Div, ZA-7599 Stellenbosch, South Africa.
   [Chellan, N.; Page, B. J.] Univ Stellenbosch, Fac Hlth Sci, ZA-7602 Matieland, South Africa.
   [Joubert, E.] Univ Stellenbosch, Dept Food Sci, ZA-7602 Matieland, South Africa.
C3 Agricultural Research Council of South Africa; Stellenbosch University; Stellenbosch University
RP Chellan, N (corresponding author), MRC, POB 19070, ZA-7505 Parow Valley, South Africa.
EM nchellan@mrc.ac.za
FU Agricultural Research Council, SA; Diabetes Discovery Platform (Medical Research Council, SA)
CR Arthur H, 2011, FOOD CHEM, V127, P581, DOI 10.1016/j.foodchem.2011.01.044
   Beltrán-Debón R, 2011, PHYTOMEDICINE, V18, P414, DOI 10.1016/j.phymed.2010.11.008
   Bowen R, 2009, ENDOCRINE PANCREAS I, V0, P0
   Cazzolli R, 2002, AM J PHYSIOL-ENDOC M, V282, PE1204, DOI 10.1152/ajpendo.00487.2001
   Chellan N, 2008, HUM EXP TOXICOL, V27, P819, DOI 10.1177/0960327108099537
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399
   de Beer D, 2011, J CHROMATOGR A, V1218, P6179, DOI 10.1016/j.chroma.2010.12.096
   DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013
   Deutschländer MS, 2009, J ETHNOPHARMACOL, V124, P619, DOI 10.1016/j.jep.2009.04.052
   Fernandez-Panchon MS, 2008, CRIT REV FOOD SCI, V48, P649, DOI 10.1080/10408390701761845
   Gray AM, 1998, J ENDOCRINOL, V157, P259, DOI 10.1677/joe.0.1570259
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   Harini Ranganathan, 2010, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V21, P79
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   HUIJING F, 1970, CLIN CHIM ACTA, V30, P567, DOI 10.1016/0009-8981(70)90246-9
   Jensen TC, 2000, J BIOL CHEM, V275, P40148, DOI 10.1074/jbc.M004902200
   Joubert E, 2011, PHENOLIC ACIDS COMPO, V0, P0
   Jung EH, 2007, J AGR FOOD CHEM, V55, P9800, DOI 10.1021/jf0714463
   Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224
   Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071
   Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002
   Mashimbye MJ, 2006, S AFR J CHEM-S-AFR T, V59, P1
   Mathews CK, 2000, BIOCHEMISTRY-US, V0, P831
   Matsuda H, 2011, BIOORGAN MED CHEM, V19, P2835, DOI 10.1016/j.bmc.2011.03.040
   Mavundza EJ, 2010, J MED PLANTS RES, V4, P2584
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Pan MH, 2010, FOOD FUNCT, V1, P15, DOI 10.1039/c0fo00103a
   Pari L, 2010, MOL CELL BIOCHEM, V341, P109, DOI 10.1007/s11010-010-0442-5
   PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166
   Prabhakar PK, 2009, PHYTOMEDICINE, V16, P1119, DOI 10.1016/j.phymed.2009.05.021
   Rampedi I, 2005, ACTA ACADEMICA, V37, P165
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van de Venter M, 2008, J ETHNOPHARMACOL, V119, P81, DOI 10.1016/j.jep.2008.05.031
   Van Wyk B E, 2000, PEOPLES PLANTS GUIDE, V0, P102
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711
   Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, PE148, DOI 10.1152/ajpendo.00211.2007
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 43
TC 13
Z9 15
U1 0
U2 18
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0944-7113
EI 
J9 PHYTOMEDICINE
JI Phytomedicine
PD JUN 15
PY 2012
VL 19
IS 8-9
BP 730
EP 736
DI 10.1016/j.phymed.2012.03.006
PG 7
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine
GA 983OF
UT WOS:000307127900012
PM 22516895
DA 2025-04-28
ER

PT J
AU Bernstein, AM
   de Koning, L
   Flint, AJ
   Rexrode, KM
   Willett, WC
AF Bernstein, Adam M.
   de Koning, Lawrence
   Flint, Alan J.
   Rexrode, Kathryn M.
   Willett, Walter C.
TI Soda consumption and the risk of stroke in men and women
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID sugar-sweetened beverages; coronary-heart-disease; cardiovascular-disease; metabolic syndrome; weight-gain; primary prevention; lifetime risk; diet; obesity; coffee
AB Background: Consumption of sugar-sweetened soda has been associated with an increased risk of cardiometabolic disease. The relation with cerebrovascular disease has not yet been closely examined. Objective: Our objective was to examine patterns of soda consumption and substitution of alternative beverages for soda in relation to stroke risk. Design: The Nurses' Health Study, a prospective cohort study of 84,085 women followed for 28 y (1980-2008), and the Health Professionals Follow-Up Study, a prospective cohort study of 43,371 men followed for 22 y (1986-2008), provided data on soda consumption and incident stroke. Results: We documented 1416 strokes in men during 841,770 person-years of follow-up and 2938 strokes in women during 2,188,230 person-years of follow-up. The pooled RR of total stroke for >= 1 serving of sugar-sweetened soda/d, compared with none, was 1.16 (95% Cl: 1.00, 1.34). The pooled RR of total stroke for >= 1 serving of low-calorie soda/d, compared with none, was 1.16(95% CI: 1.05, 1.28), Compared with 1 serving of sugar-sweetened soda/d, 1 serving of decaffeinated coffee/d was associated with a 10% (95% Cl: 1%, 19%) lower risk of stroke and 1 serving of caffeinated coffee/d with a 9% (95% Cl: 0%, 17%) lower risk. Similar estimated reductions in risk were seen for substitution of caffeinated or decaffeinated coffee for low-calorie soda. Conclusions: Greater consumption of sugar-sweetened and low-calorie sodas was associated with a significantly higher risk of stroke. This risk may be reduced by substituting alternative beverages for soda. Am J Clin Nutr 2012;95:1190-9.
C1 [Bernstein, Adam M.] Cleveland Clin, Wellness Inst, Lyndhurst, OH 44124 USA.
   [Bernstein, Adam M.; de Koning, Lawrence; Flint, Alan J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Flint, Alan J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Flint, Alan J.; Willett, Walter C.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA.
   [Rexrode, Kathryn M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
C3 Cleveland Clinic Foundation; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard Medical School
RP Bernstein, AM (corresponding author), Cleveland Clin, Wellness Inst, 1950 Richmond Road,TR2-203, Lyndhurst, OH 44124 USA.
EM bernsta2@ccf.org
FU NIH, Department of Health and Human Services [P01CA087969, U19 CA055075-20]; Harvard Human Nutrition Program
CR Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013
   Unknown -, 1981, STROKE, V0, P0
   Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165
   Bray GA, 2007, AM J CLIN NUTR, V86, P895, DOI 10.1093/ajcn/86.4.895
   Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939
   Choi Hyon K, 2010, JAMA (JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION), V304, P2270, DOI 10.1001/jama.2010.1638
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Ding EL, 2006, SEMIN NEUROL, V26, P11, DOI 10.1055/s-2006-933305
   Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193
   FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810
   Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238
   Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317
   Halton TL, 2006, AM J CLIN NUTR, V83, P284
   Hu FB, 1999, AM J CLIN NUTR, V70, P1001
   Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Johnson RJ, 2007, AM J CLIN NUTR, V86, P899
   Lin J, 2011, CLIN J AM SOC NEPHRO, V6, P160, DOI 10.2215/CJN.03260410
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Malik VS, 2009, AM J CLIN NUTR, V89, P438, DOI 10.3945/ajcn.2008.26980
   Mattes Richard D, 1996, PHYSIOLOGY AND BEHAVIOR, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726
   Mostofsky E, 2010, NEUROLOGY, V75, P1583, DOI 10.1212/WNL.0b013e3181fb443d
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Mukamal KJ, 2004, AM HEART J, V147, P999, DOI 10.1016/j.ahj.2003.12.038
   Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75
   Preis SR, 2010, AM J CLIN NUTR, V91, P39, DOI 10.3945/ajcn.2009.28060
   SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2
   STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804
   Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
   WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
NR 42
TC 140
Z9 150
U1 3
U2 27
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD MAY 15
PY 2012
VL 95
IS 5
BP 1190
EP 1199
DI 10.3945/ajcn.111.030205
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 930LK
UT WOS:000303140700025
PM 22492378
DA 2025-04-28
ER

PT J
AU Bansal, S
   Syan, N
   Mathur, P
   Choudhary, S
AF Bansal, Sumit
   Syan, Navneet
   Mathur, Pooja
   Choudhary, Shivani
TI Pharmacological profile of green tea and its polyphenols: a review
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Review
DE Catechins; Epigallocatechin-3-gallate (EGCG); Green Tea; Polyphenols
ID epigallocatechin gallate; (-)-epigallocatechin gallate; oxidative-stress; antioxidant activity; precursor protein; induced gastritis; blood-pressure; cancer risk; black tea; catechins
AB Tea (Camellia sinensis, Theaceae) is the second most consumed beverages in the world, next to water in terms of worldwide popularity. The chemical components of green tea chiefly include polyphenols, caffeine, and amino acids. Green tea is rich in catechins, of which (-)-epigallocatechin-3-gallate is the most abundant. As described in literature, green tea and its polyphenols are beneficial in curing a wide variety of diseases like cancer, diabetes, cardiovascular disease, obesity, etc. It also has antimicrobial activity, protects from solar radiations, and possesses neuroprotective properties. The current review article focuses on pharmacological profile associated with Green tea and its polyphenols. We hope that this review will expose areas for further study and encourage research on important public health issue.
C1 [Bansal, Sumit; Syan, Navneet; Mathur, Pooja] Ganpati Inst Pharm, Dept Pharmaceut Chem, Yamunanagar 135102, Haryana, India.
   [Choudhary, Shivani] Doon Valley Inst Pharm & Med, Karnal 132001, Haryana, India.
RP Bansal, S (corresponding author), Ganpati Inst Pharm, Dept Pharmaceut Chem, Yamunanagar 135102, Haryana, India.
EM bansalsumit50@gmail.com
CR Abdel-Raheem IT, 2010, PAK J PHARM SCI, V23, P21
   Akgün H, 2009, TURK J CHEM, V33, P107, DOI 10.3906/kim-0807-25
   Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794
   Al-Attar Atef M, 2010, SAUDI J BIOL SCI, V17, P295, DOI 10.1016/j.sjbs.2010.05.007
   Atoui AK, 2005, FOOD CHEM, V89, P27, DOI 10.1016/j.foodchem.2004.01.075
   Bisht GS, 2007, BIOORG MED CHEM LETT, V17, P4343, DOI 10.1016/j.bmcl.2007.05.015
   Blanco AR, 2005, ANTIMICROB AGENTS CH, V49, P4339, DOI 10.1128/AAC.49.10.4339-4343.2005
   Boschmann M, 2007, J AM COLL NUTR, V26, P389S, DOI 10.1080/07315724.2007.10719627
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Carlson JR, 2007, MAYO CLIN PROC, V82, P725
   Carvalho M, 2010, FOOD CHEM, V122, P49, DOI 10.1016/j.foodchem.2010.02.014
   Chacko Sabu M, 2010, CHIN MED, V5, P13, DOI 10.1186/1749-8546-5-13
   Chan CM, 2010, MOL VIS, V16, P586
   Chan CM, 2008, MOL VIS, V14, P2528
   Chen AP, 2002, BIOCHEM J, V368, P695, DOI 10.1042/BJ20020894
   Chen XQ, 2010, CARBOHYD POLYM, V82, P28, DOI 10.1016/j.carbpol.2010.04.017
   Cheng TO, 2006, INT J CARDIOL, V108, P301, DOI 10.1016/j.ijcard.2005.05.038
   Chrostek L, 2005, ROCZ AKAD MED BIALYMST, V50, P220
   Chyu KY, 2004, CIRCULATION, V109, P2448, DOI 10.1161/01.CIR.0000128034.70732.C2
   Clement Y, 2009, PREV MED, V49, P83, DOI 10.1016/j.ypmed.2009.05.005
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210
   El-Shahat AE, 2009, INT J MORPHOL, V27, P757
   Finkel R, 2009, PHARMACOLOGY, V0, P215
   Frei B, 2003, J NUTR, V133, P3275S, DOI 10.1093/jn/133.10.3275S
   Gordon NC, 2010, INT J ANTIMICROB AG, V36, P129, DOI 10.1016/j.ijantimicag.2010.03.025
   Hao J, 2007, J VET SCI, V8, P121, DOI 10.4142/jvs.2007.8.2.121
   Hara-Kudo Y, 2005, J SCI FOOD AGR, V85, P2354, DOI 10.1002/jsfa.2259
   Hauber I, 2009, P NATL ACAD SCI USA, V106, P9033, DOI 10.1073/pnas.0811827106
   Hirasawa M, 2004, J ANTIMICROB CHEMOTH, V53, P225, DOI 10.1093/jac/dkh046
   Hirasawa M, 2002, J PERIODONTAL RES, V37, P433, DOI 10.1034/j.1600-0765.2002.01640.x
   Hofmann CS, 2003, FASEB J, V17, P702, DOI 10.1096/fj.02-0665fje
   Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177
   Imanishi N, 2002, MICROBIOL IMMUNOL, V46, P491, DOI 10.1111/j.1348-0421.2002.tb02724.x
   Joshi S, 2010, BBA-BIOMEMBRANES, V1798, P1864, DOI 10.1016/j.bbamem.2010.06.016
   Juneja VK, 2007, J FOOD PROTECT, V70, P1429, DOI 10.4315/0362-028X-70.6.1429
   Kang KW, 2010, FOOD CHEM, V121, P1089, DOI 10.1016/j.foodchem.2010.01.055
   Karaca T, 2010, J ANIM VET ADV, V9, P102
   Kaszkin M, 2004, MOL PHARMACOL, V65, P15, DOI 10.1124/mol.65.1.15
   Katiyar SK, 2001, CARCINOGENESIS, V22, P287, DOI 10.1093/carcin/22.2.287
   Katiyar SK, 2001, J LEUKOCYTE BIOL, V69, P719
   Kim SH, 2008, J WOMENS MED, V1, P27
   Kim Yong Wook, 2004, CANCER RES TREAT, V36, P315, DOI 10.4143/crt.2004.36.5.315
   Koizumi Y, 2003, CANCER EPIDEM BIOMAR, V12, P472
   Kuriyama S, 2006, AM J CLIN NUTR, V83, P355
   Lee MJ, 2004, CANCER EPIDEM BIOMAR, V13, P132, DOI 10.1158/1055-9965.EPI-03-0040
   Leung LK, 2001, J NUTR, V131, P2248, DOI 10.1093/jn/131.9.2248
   Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881fje
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200
   Maeta K, 2007, APPL ENVIRON MICROB, V73, P572, DOI 10.1128/AEM.01963-06
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Maruyama K, 2009, J CLIN BIOCHEM NUTR, V44, P41, DOI 10.3164/jcbn.08-13
   Matsubara S, 2003, BIOCHEM BIOPH RES CO, V310, P715, DOI 10.1016/j.bbrc.2003.09.066
   McNaught JG, 1906, J. R. ARMY MED. CORPS, V7, P372
   Meeran SM, 2009, J INVEST DERMATOL, V129, P1258, DOI 10.1038/jid.2008.354
   Mildner-Szkudlarz S, 2009, J FOOD SCI, V74, PS362, DOI 10.1111/j.1750-3841.2009.01313.x
   Mimoto J, 2000, CARCINOGENESIS, V21, P915, DOI 10.1093/carcin/21.5.915
   Miura T, 2005, J HEALTH SCI, V51, P708, DOI 10.1248/jhs.51.708
   Mughal T, 2010, J APP PHARM, V2, P60
   Mukhtar H, 2000, AM J CLIN NUTR, V71, P1698S, DOI 10.1093/ajcn/71.6.1698S
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Navarro-Martínez MD, 2005, ANTIMICROB AGENTS CH, V49, P2914, DOI 10.1128/AAC.49.7.2914-2920.2005
   Negishi H, 2004, J NUTR, V134, P38, DOI 10.1093/jn/134.1.38
   Ng TP, 2008, AM J CLIN NUTR, V88, P224, DOI 10.1093/ajcn/88.1.224
   Papparella I, 2008, J NUTR, V138, P1596, DOI 10.1093/jn/138.9.1596
   Park JH, 2009, J PHYSIOL PHARMACOL, V60, P101
   Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, PE1378, DOI 10.1152/ajpendo.00698.2006
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005
   Rietveld A, 2003, J NUTR, V133, P3285S, DOI 10.1093/jn/133.10.3285S
   Roy AM, 2005, MOL CANCER THER, V4, P81
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Ruggiero P, 2007, WORLD J GASTROENTERO, V13, P349, DOI 10.3748/wjg.v13.i3.349
   Sakanaka S, 2000, J BIOSCI BIOENG, V90, P81, DOI 10.1016/S1389-1723(00)80038-9
   Sartippour MR, 2006, CARCINOGENESIS, V27, P2424, DOI 10.1093/carcin/bgl066
   Sharangi AB, 2009, FOOD RES INT, V42, P529, DOI 10.1016/j.foodres.2009.01.007
   Sinha D, 2010, FOOD CHEM TOXICOL, V48, P1032, DOI 10.1016/j.fct.2010.01.016
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Stapleton PD, 2006, INT J FOOD MICROBIOL, V111, P276, DOI 10.1016/j.ijfoodmicro.2006.06.005
   Stoicov C, 2009, INT J ANTIMICROB AG, V33, P473, DOI 10.1016/j.ijantimicag.2008.10.032
   Suganuma M, 1999, CANCER RES, V59, P44
   Sutherland BA, 2004, FASEB J, V18, P258, DOI 10.1096/fj.04-2806fje
   Tanaka T, 2011, FREE RADICAL BIO MED, V50, P1324, DOI 10.1016/j.freeradbiomed.2011.01.024
   Taylor Peter W, 2005, FOOD SCI TECHNOL BULL, V2, P71, DOI 10.1616/1476-2137.14184
   Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903
   Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200
   Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200
   West PWJ, 2001, JOURNAL OF NUTRITIONAL AND ENVIRONMENTAL MEDICINE (ABINGDON), V11, P263, DOI 10.1080/13590840120103102
   Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016
   Wolfram S, 2006, J NUTR, V136, P2512, DOI 10.1093/jn/136.10.2512
   Xu JZ, 2004, BRIT J NUTR, V91, P873, DOI 10.1079/BJN20041132
   Yang G, 2007, CANCER EPIDEM BIOMAR, V16, P1219, DOI 10.1158/1055-9965.EPI-07-0097
   Yao K, 2008, MOL VIS, V14, P217
   Yee YK, 2000, ALIMENT PHARM THER, V14, P635, DOI 10.1046/j.1365-2036.2000.00747.x
   Yi SM, 2010, INT J FOOD MICROBIOL, V144, P111, DOI 10.1016/j.ijfoodmicro.2010.09.005
   Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176
   Yuan JM, 2005, CARCINOGENESIS, V26, P1389, DOI 10.1093/carcin/bgi080
   Zapora E, 2009, B VET I PULAWY, V53, P139
   Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006
   Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200
   Zhang ZF, 2010, PHYTOMEDICINE, V17, P14, DOI 10.1016/j.phymed.2009.09.007
   Zheng GD, 2004, IN VIVO, V18, P55
NR 105
TC 43
Z9 55
U1 4
U2 169
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD NOV 15
PY 2012
VL 21
IS 11
BP 3347
EP 3360
DI 10.1007/s00044-011-9800-4
PG 14
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 014AY
UT WOS:000309348600003
DA 2025-04-28
ER

PT J
AU Hervert-Hernández, D
   Goñi, I
AF Hervert-Hernandez, Deisy
   Goni, Isabel
TI Contribution of beverages to the intake of polyphenols and antioxidant capacity in obese women from rural Mexico
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Polyphenols; Antioxidant activity; Obesity; Beverages; Mexican diet
ID sugar-sweetened beverages; consumption; adolescents; nutrition; risk
AB Objective: The aims of the present work were to study beverage consumption among obese women from rural communities in Mexico and to estimate daily polyphenol intake and dietary antioxidant capacity from beverages. Design: A cross-sectional study was used to analyse the beverage intake of 139 premenopausal obese women estimated through repeated 24 h food recalls. Total polyphenol content and antioxidant capacity were determined in eighteen beverages, representing 71% of total beverage consumption, in order to estimate the intake of polyphenols (mg/person per cl) and the dietary antioxidant capacity (mu mol Trolox equivalents/person per d) from beverages. Setting: Five rural communities located in Queretaro State, Mexico, in 2008. Subjects: A total of 139 premenopausal women identified as obese (BMI 35.0 (SE 0.4) kg/m(2)), aged 25-45 years. Results: The contribution of beverages to dietary energy was 1369 kJ/d (18% of total energy intake). Soft drinks were consumed the most (283 (SE 17) ml/d), followed by coffee and fresh fruit beverages. Polyphenol intake and dietary antioxidant capacity from beverages was 180.9 (SE 12.5) mg/person per d and >1000 mu mol Trolox equivalents/person per cl, respectively. The items that contributed most to this intake were coffee, roselle chink, peach and guava juices and infusions. Conclusions: There is an urgent need to reduce the consumption of sugar-sweetened beverages among obese women from rural Mexico. Low-sugar beverages rich in polyphenols and antioxidants may be healthier options to replace sweetened drinks and increase the intake of bioactive compounds. Nutritional advice on this topic could be a viable strategy to tackle obesity in rural areas in Mexico.
C1 [Hervert-Hernandez, Deisy; Goni, Isabel] Univ Complutense Madrid, Fac Pharm, Dept Nutr & Bromatol 1, Nutr & Gastrointestinal Hlth Unit, E-28040 Madrid, Spain.
C3 Complutense University of Madrid
RP Goñi, I (corresponding author), Univ Complutense Madrid, Fac Pharm, Dept Nutr & Bromatol 1, Nutr & Gastrointestinal Hlth Unit, E-28040 Madrid, Spain.
EM igonic@farm.ucm.es
FU Spanish Ministry of Science and Innovation [AGL-2008-01633]; Mexican institutions, National Council on Science and Technology and Secretariat of Public Education; National Program of I + D
CR Almajano MP, 2008, FOOD CHEM, V108, P55, DOI 10.1016/j.foodchem.2007.10.040
   Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163
   Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701
   Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368
   Chen LW, 2010, CIRCULATION, V121, P2398, DOI 10.1161/CIRCULATIONAHA.109.911164
   Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240
   Dennis EA, 2009, EAT BEHAV, V10, P237, DOI 10.1016/j.eatbeh.2009.07.006
   Denova-Gutiérrez E, 2010, PUBLIC HEALTH NUTR, V13, P835, DOI 10.1017/S1368980009991145
   Dolara P, 2005, MUTAT RES-FUND MOL M, V591, P237, DOI 10.1016/j.mrfmmm.2005.04.022
   Ferk F, 2010, MUTAT RES-FUND MOL M, V691, P17, DOI 10.1016/j.mrfmmm.2010.06.006
   Ferruzzi MG, 2010, PHYSIOL BEHAV, V100, P33, DOI 10.1016/j.physbeh.2010.01.035
   Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662
   Hervert-Hernández D, 2011, FOOD RES INT, V44, P1182, DOI 10.1016/j.foodres.2010.09.021
   Hofmann SM, 2009, J CLIN INVEST, V119, P1089, DOI 10.1172/JCI39332
   Ibarra-Alvarado C, 2010, PHARM BIOL, V48, P732, DOI 10.3109/13880200903271280
   Jimenez-Aguilar A, 2009, SALUD PUBLICA MEX S4, V51, P0
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Montreau F, 1972, CONNAIS VIGNE VIN, V24, P397, DOI 10.20870/OENO-ONE.1972.6.4.2071
   Neufeld LM, 2008, OBESITY, V16, P714, DOI 10.1038/oby.2007.119
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Pérez-Jiménez J, 2008, FOOD RES INT, V41, P274, DOI 10.1016/j.foodres.2007.12.004
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Rivera JA, 2004, NUTR REV, V62, PS149, DOI 10.1111/j.1753-4887.2004.tb00086.x
   Rivera JA, 2008, SALUD PUBLICA MEXICO, V50, P173, DOI 10.1590/S0036-36342008000200011
   Saura-Calixto F, 2006, FOOD CHEM, V94, P442, DOI 10.1016/j.foodchem.2004.11.033
   Saura-Calixto F, 2007, FOOD CHEM, V101, P492, DOI 10.1016/j.foodchem.2006.02.006
   Sayago-Ayerdi SG, 2007, J AGR FOOD CHEM, V55, P7886, DOI 10.1021/jf070485b
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Woodward-Lopez G, 2010, PUBLIC HLTH NUTR, V0, P0
NR 29
TC 14
Z9 15
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JAN 15
PY 2012
VL 15
IS 1
BP 6
EP 12
DI 10.1017/S1368980011001753
PG 7
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA 882WK
UT WOS:000299594400003
PM 21806865
DA 2025-04-28
ER

PT J
AU Stohs, SJ
   Preuss, HG
   Shara, M
AF Stohs, Sidney J.
   Preuss, Harry G.
   Shara, Mohd
TI A Review of the Human Clinical Studies Involving Citrus aurantium (Bitter Orange) Extract and its Primary Protoalkaloid p-Synephrine
SO INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
LA English
DT Review
DE Citrus aurantium; bitter orange; p-synephrine; human subjects; obesity/overweight; safety; efficacy; caffeine
ID blood-pressure; heart-rate; dietary-supplement; metabolic-rate; green tea; caffeine; efficacy; safety; juice
AB This review summarizes the published as well as unpublished human studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine, providing information and an assessment of the safety and efficacy of these widely used products. The results of over 20 studies involving a total of approximately 360 subjects that consumed p-synephrine alone or in combination with other ingredients are reviewed and critiqued. Over 50% of the subjects involved in these studies were overweight/obese, and approximately two-thirds of these overweight/obese subjects consumed caffeine (132-528 mg/day) in conjunction with p-synephrine (10-53 mg/day). Bitter orange/p-synephrine containing products were consumed for up to 12 weeks. Approximately 44 % of the subjects consumed a bitter orange/p-synephrine only product, while the remainder consumed a complex product that contained multiple ingredients in addition to p-synephrine. In general, bitter orange extract alone (p-synephrine) or in combination with other herbal ingredients did not produce significant adverse events as an increase in heart rate or blood pressure, or alter electrocardiographic data, serum chemistry, blood cell counts or urinalysis. p-Synephrine alone as well as in combination products were shown to increase resting metabolic rate and energy expenditure, and modest increases in weight loss were observed with bitter orange extract/p-synephrine-containing products when given for six to 12 weeks. Longer term studies are needed to further assess the efficacy of these products and affirm their safety under these conditions.
C1 [Preuss, Harry G.] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20039 USA.
   [Preuss, Harry G.] Georgetown Univ, Med Ctr, Dept Pathol & Med, Washington, DC 20039 USA.
   [Stohs, Sidney J.] Creighton Univ, Med Ctr, Omaha, NE 68078 USA.
   [Shara, Mohd] Jordan Univ Sci & Technol, Fac Pharm, Irbid 22110, Jordan.
C3 Georgetown University; Georgetown University; Creighton University; Jordan University of Science & Technology
RP Preuss, HG (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20039 USA.
EM preusshg@georgetown.edu
CR Avula B, 2005, J AOAC INT, V88, P1593
   Bent S, 2004, AM J CARDIOL, V94, P1359, DOI 10.1016/j.amjcard.2004.07.137
   Bloomer RJ, 2009, LIPIDS HEALTH DIS, V8, P0, DOI 10.1186/1476-511X-8-32
   Bloomer RJ, 2009, J INT SOC SPORT NUTR, V6, P0, DOI 10.1186/1550-2783-6-4
   Bui LT, 2006, ANN PHARMACOTHER, V40, P53, DOI 10.1345/aph.1G488
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   Dragull K, 2008, J AGR FOOD CHEM, V56, P8874, DOI 10.1021/jf801225n
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Evans RL, 2008, J CHROMATOGR SCI, V46, P61, DOI 10.1093/chromsci/46.1.61
   Gougeon R, 2005, OBES RES, V13, P1187, DOI 10.1038/oby.2005.141
   Gurley BJ, 2004, CLIN PHARMACOL THER, V76, P428, DOI 10.1016/j.clpt.2004.07.007
   Haller CA, 2005, AM J MED, V118, P998, DOI 10.1016/j.amjmed.2005.02.034
   Haller CA, 2008, BRIT J CLIN PHARMACO, V65, P833, DOI 10.1111/j.1365-2125.2008.03144.x
   Hansen DK, 2012, TOXICOL APPL PHARM, V0, P0, DOI DOI 10.1016/j.tap.2012.04.006
   HENGSTMANN JH, 1978, ARZNEIMITTEL-FORSCH, V28-2, P2326
   Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, P0, DOI 10.1186/1550-2783-6-1
   Hoffman Jay R, 2006, J INT SOC SPORTS NUTR, V3, P35, DOI 10.1186/1550-2783-3-1-35
   Kalman D, 2002, INT J OBESITY, V26, P1363, DOI 10.1038/sj.ijo.0802061
   Kalman DS, 2004, INT J OBESITY, V28, P1355, DOI 10.1038/sj.ijo.0802418
   Kalman DS, 2000, CURR THER RES CLIN E, V61, P199, DOI 10.1016/S0011-393X(00)89034-7
   Kalman DS, 2002, J AM COLL NUTR, V21, P488
   Kalman DS, 2003, FED AM SOC EXP UNPUB, V0, P0
   Kalman DS, 2002, M NIH NAT I DI UNPUB, V0, P0
   Karch Steven B, 2007, J FORENSIC LEG MED, V14, P79, DOI 10.1016/j.jcfm.2006.02.022
   Kendall-Reed P, 2000, STUDY EFFECTIV UNPUB, V0, P0
   McGuffin M, 2006, HERBALGRAM, V69, P52
   Mercolini L, 2010, J SEP SCI, V33, P23, DOI 10.1002/jssc.200900493
   Min B, 2005, PHARMACOTHERAPY, V25, P1719, DOI 10.1592/phco.2005.25.12.1719
   Moens AL, 2010, J MOL CELL CARDIOL, V48, P1088, DOI 10.1016/j.yjmcc.2010.02.011
   Nasir JM, 2004, MAYO CLIN PROC, V79, P1059, DOI 10.4065/79.8.1059
   Pellati F, 2007, J CHROMATOGR A, V1161, P71, DOI 10.1016/j.chroma.2007.05.097
   Penzak SR, 2001, J CLIN PHARMACOL, V41, P1059, DOI 10.1177/00912700122012652
   Percy DW, 2010, TALANTA, V80, P2191, DOI 10.1016/j.talanta.2009.10.052
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Riksen Niels P, 2011, HANDB EXP PHARMACOL, V0, PP413, DOI 10.1007/978-3-642-13443-2_16
   Rozec B, 2006, PHARMACOL THERAPEUT, V111, P652, DOI 10.1016/j.pharmthera.2005.12.002
   Sale C, 2006, INT J OBESITY, V30, P764, DOI 10.1038/sj.ijo.0803209
   Sander LC, 2008, ANAL BIOANAL CHEM, V391, P2023, DOI 10.1007/s00216-008-2074-0
   Seifert JG, 2011, INT J MED SCI, V8, P192, DOI 10.7150/ijms.8.192
   Shara M, 2012, J AM COLL NUTR, V30, P358
   Slezak T, 2007, ANAL CHIM ACTA, V593, P98, DOI 10.1016/j.aca.2007.04.038
   Stephensen TA, 2009, MIL MED, V174, P1313, DOI 10.7205/MILMED-D-01-5009
   Stohs SJ, 2012, J FUNCT FOODS, V4, P2, DOI 10.1016/j.jff.2011.09.004
   Stohs SJ, 2011, PHYTOTHER RES, V25, P1421, DOI 10.1002/ptr.3490
   Stohs SJ, 2011, OXID MED CELL LONGEV, V2011, P0, DOI 10.1155/2011/482973
   Stohs SJ, 2011, INT J MED SCI, V8, P295, DOI 10.7150/ijms.8.295
   Stohs SJ, 2010, J FUNCT FOODS, V2, P235, DOI 10.1016/j.jff.2010.10.003
   Talbott SM, 2007, CITRUS AURANTI UNPUB, V0, P0
   Uckoo RM, 2011, TALANTA, V83, P948, DOI 10.1016/j.talanta.2010.10.063
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Zenk JL, 2005, NUTRITION, V21, P179, DOI 10.1016/j.nut.2004.05.025
   Zenk JL, 2005, PROSPECTIVE RA UNPUB, V0, P0
NR 55
TC 88
Z9 107
U1 2
U2 57
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-1907
EI 
J9 INT J MED SCI
JI Int. J. Med. Sci.
PD JUN 15
PY 2012
VL 9
IS 7
BP 527
EP 538
DI 10.7150/ijms.4446
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA 024SI
UT WOS:000310128500003
PM 22991491
DA 2025-04-28
ER

PT J
AU Cha, KH
   Song, DG
   Kim, SM
   Pan, CH
AF Cha, Kwang Hyun
   Song, Dae-Geun
   Kim, Sang Min
   Pan, Cheol-Ho
TI Inhibition of Gastrointestinal Lipolysis by Green Tea, Coffee, and Gomchui (Ligularia fischeri) Tea Polyphenols during Simulated Digestion
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE EGCG; DCQA; lipase inhibition; green tea; coffee; Ligularia fischeri; simulated digestion
ID lipase in-vitro; pancreatic lipase; chlorogenic acid; antioxidant activity; black tea; catechins; bioavailability; ingestion; identification; inflammation
AB Green tea, coffee, and gomchui (Ligularia fischeri) tea, which are rich in polyphenols, may exhibit antiobesity effects by inhibiting pancreatic lipase. However, the bioavailability of some polyphenols is poor due to either degradation or absorption difficulties in the gastrointestinal tract, thus making their beneficial effects doubtful. This study was conducted,to evaluate the inhibitory effect of three beverages on lipolysis and the contribution of their major polyphenols during simulated digestion. During simulated digestion, gomchui tea was the most potent at inhibiting gastrointestinal lipolysis, whereas green tea was the least potent. The strongest lipase inhibitor among purified major polyphenols was a green tea polyphenol, (-)-epigallocatechin gallate (EGCG, IC50 = 1.8 +/- 0.57 mu M), followed by di-O-caffeoylquinic acid isomers (DCQA, IC50 from 12.7 +/- 4.5 to 404 +/- 23 mu M), which are gomchui tea polyphenols. However, the stability of DCQA was greater than that of EGCG when subjected to simulated digestion. Taken together, gomchui tea, which has DCQA as the major polyphenol, showed stronger lipolysis inhibitory activity during simulated digestion compared to both green tea and coffee.
C1 [Cha, Kwang Hyun; Song, Dae-Geun; Kim, Sang Min; Pan, Cheol-Ho] Korea Inst Sci & Technol, Funct Food Ctr, Kangnung 210340, South Korea.
C3 Korea Institute of Science & Technology (KIST)
RP Pan, CH (corresponding author), Korea Inst Sci & Technol, Funct Food Ctr, Kangnung 210340, South Korea.
EM cheolpan@gmail.com
FU Korea Institute of Science and Technology Gangneung Institute [2Z03560]
CR Almoosawi S, 2010, NUTR BULL, V35, P207, DOI 10.1111/j.1467-3010.2010.01841.x
   Amaki K, 2011, BIOSCI BIOTECH BIOCH, V75, P829, DOI 10.1271/bbb.100444
   Unknown -, 1976, BIOCHEM J, V0, P0
   Arts ICW, 2000, J AGR FOOD CHEM, V48, P1752, DOI 10.1021/jf000026+
   Bonfili L, 2011, BIOCHIMIE, V93, P931, DOI 10.1016/j.biochi.2011.02.003
   Chen WW, 2012, DRUG METAB LETT, V0, P0, DOI DOI 10.2174/ 1872212225945643128
   Garrett DA, 1999, J AGR FOOD CHEM, V47, P4301, DOI 10.1021/jf9903298
   Gondoin A, 2010, FOOD RES INT, V43, P1537, DOI 10.1016/j.foodres.2010.04.029
   Green RJ, 2007, MOL NUTR FOOD RES, V51, P1152, DOI 10.1002/mnfr.200700086
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Guo YQ, 2009, NUTR RES, V29, P656, DOI 10.1016/j.nutres.2009.09.005
   HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357
   Han C, 1997, CANCER LETT, V114, P153, DOI 10.1016/S0304-3835(97)04647-8
   Han LK, 2001, INT J OBESITY, V25, P1459, DOI 10.1038/sj.ijo.0801747
   Hashimoto F, 1996, BIOORG MED CHEM LETT, V6, P695, DOI 10.1016/0960-894X(96)00095-9
   Henning SM, 2004, AM J CLIN NUTR, V80, P1558
   Highlander Peter, 2010, THER ADV CARDIOVASC DIS, V4, P43, DOI 10.1177/1753944709354305
   Jumtee K, 2009, J SEP SCI, V32, P2296, DOI 10.1002/jssc.200900096
   Karu N, 2007, J AGR FOOD CHEM, V55, P2824, DOI 10.1021/jf0628025
   Kim CY, 2008, FOOD SCI BIOTECHNOL, V17, P846
   Kotani A, 2003, J CHROMATOGR B, V788, P269, DOI 10.1016/S1570-0232(02)01036-X
   Krul C, 2001, MUTAT RES-FUND MOL M, V474, P71, DOI 10.1016/S0027-5107(00)00158-5
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   Lee JE, 2011, J AGR FOOD CHEM, V59, P10579, DOI 10.1021/jf202304z
   Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
   Lee YS, 2010, CYTOTECHNOLOGY, V62, P367, DOI 10.1007/s10616-010-9288-7
   LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2
   McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948
   McClendon KS, 2009, EXPERT OPIN DRUG SAF, V8, P727, DOI 10.1517/14740330903321485
   McDougall GJ, 2008, BIOFACTORS, V34, P73, DOI 10.1002/biof.5520340108
   Mullen W, 2011, J AGR FOOD CHEM, V59, P3754, DOI 10.1021/jf200122m
   Murase T, 2012, BRIT J NUTR, V107, P1757, DOI 10.1017/S0007114511005083
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Neilson AP, 2007, J AGR FOOD CHEM, V55, P8941, DOI 10.1021/jf071645m
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Parada J, 2007, J FOOD SCI, V72, PR21, DOI 10.1111/j.1750-3841.2007.00274.x
   Pecorari M, 2010, MOL NUTR FOOD RES, V54, PS278, DOI 10.1002/mnfr.200900583
   Renouf M, 2011, EUR J NUTR, V50, P575, DOI 10.1007/s00394-010-0164-1
   Richelle M, 2001, J AGR FOOD CHEM, V49, P3438, DOI 10.1021/jf0101410
   Shang YF, 2010, J FOOD SCI, V75, PC530, DOI 10.1111/j.1750-3841.2010.01714.x
   Sugiyama H, 2007, J AGR FOOD CHEM, V55, P4604, DOI 10.1021/jf070569k
   Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Yoshikawa M, 2002, J NUTR, V132, P1819, DOI 10.1093/jn/132.7.1819
   Yoshino K, 1999, J NUTR BIOCHEM, V10, P223, DOI 10.1016/S0955-2863(98)00103-X
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
NR 47
TC 73
Z9 80
U1 5
U2 121
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUL 25
PY 2012
VL 60
IS 29
BP 7152
EP 7157
DI 10.1021/jf301047f
PG 6
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 978EV
UT WOS:000306724300009
PM 22730927
DA 2025-04-28
ER

PT J
AU Jurgens, TM
   Whelan, AM
   Killian, L
   Doucette, S
   Kirk, S
   Foy, E
AF Jurgens, Tannis M.
   Whelan, Anne Marie
   Killian, Lara
   Doucette, Steve
   Kirk, Sara
   Foy, Elizabeth
TI Green tea for weight loss and weight maintenance in overweight or obese adults
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID randomized-controlled-trial; body-weight; energy-expenditure; fat oxidation; double-blind; insulin-resistance; abdominal fat; risk-factors; caffeine; catechins
AB Background Preparations of green tea are used as aids in weight loss and weight maintenance. Catechins and caffeine, both contained in green tea, are each believed to have a role in increasing energy metabolism, which may lead to weight loss. A number of randomised controlled trials (RCTs) evaluating the role of green tea in weight loss have been published; however, the efficacy of green tea preparations in weight loss remains unclear. Objectives To assess the efficacy and safety of green tea preparations for weight loss and weight maintenance in overweight or obese adults. Search methods We searched the following databases from inception to specified date as well as reference lists of relevant articles: The Cochrane Library (Issue 12, 2011), MEDLINE (December 2011), EMBASE (December 2011), CINAHL (January 2012), AMED (January 2012), Biological Abstracts (January 2012), IBIDS (August 2010), Obesity+ (January 2012), IPA (January 2012) and Web of Science (December 2011). Current Controlled Trials with links to other databases of ongoing trials was also searched. Selection criteria RCTs of at least 12 weeks' duration comparing green tea preparations to a control in overweight or obese adults. Data collection and analysis Three authors independently extracted data, assessed studies for risk of bias and quality, with differences resolved by consensus. Heterogeneity of included studies was assessed visually using forest plots and quantified using the I-2 statistic. We synthesised data using meta-analysis and descriptive analysis as appropriate; subgroup and sensitivity analyses were conducted. Adverse effects reported in studies were recorded. Main results Due to the level of heterogeneity among studies, studies were divided into two groups; those conducted in Japan and those conducted outside Japan. Study length ranged between 12 and 13 weeks. Meta-analysis of six studies conducted outside Japan showed a mean difference (MD) in weight loss of -0.04 kg (95% CI -0.5 to 0.4; P = 0.88; I-2 = 18%; 532 participants). The eight studies conducted in Japan were not similar enough to allow pooling of results and MD in weight loss ranged from -0.2 kg to -3.5 kg (1030 participants) in favour of green tea preparations. Meta-analysis of studies measuring change in body mass index (BMI) conducted outside Japan showed a MD in BMI of -0.2 kg/m(2) (95% CI -0.5 to 0.1; P = 0.21; I-2 = 38%; 222 participants). Differences among the eight studies conducted in Japan did not allow pooling of results and showed a reduction in BMI ranging from no effect to -1.3 kg/m(2) (1030 participants), in favour of green tea preparations over control. Meta-analysis of five studies conducted outside Japan and measuring waist circumference reported a MD of -0.2 cm (95% CI -1.4 to 0.9; P = 0.70; I2 = 58%; 404 participants). Differences among the eight studies conducted in Japan did not allow pooling of results and showed effects on waist circumference ranging from a gain of 1 cm to a loss of 3.3 cm (1030 participants). Meta-analysis for three weight loss studies, conducted outside Japan, with waist-to-hip ratio data (144 participants) yielded no significant change (MD 0; 95% CI -0.02 to 0.01). Analysis of two studies conducted to determine if green tea could help to maintain weight after a period of weight loss (184 participants) showed a change in weight loss of 0.6 to -1.6 kg, a change in BMI from 0.2 to -0.5 kg/m(2) and a change in waist circumference from 0.3 to -1.7 cm. In the eight studies that recorded adverse events, four reported adverse events that were mild to moderate, with the exception of two (green tea preparations group) that required hospitalisation (reported as not associated with the intervention). Nine studies reported on compliance/adherence, one study assessed attitude towards eating as part of the health-related quality of life outcome. No studies reported on patient satisfaction, morbidity or cost. Authors' conclusions Green tea preparations appear to induce a small, statistically non-significant weight loss in overweight or obese adults. Because the amount of weight loss is small, it is not likely to be clinically important. Green tea had no significant effect on the maintenance of weight loss. Of those studies recording information on adverse events, only two identified an adverse event requiring hospitalisation. The remaining adverse events were judged to be mild to moderate.
C1 [Jurgens, Tannis M.; Whelan, Anne Marie; Foy, Elizabeth] Dalhousie Univ, Coll Pharm, Halifax, NS B3H 4R2, Canada.
   [Killian, Lara] Nova Scotia Cochrane Resource Ctr, Halifax, NS, Canada.
   [Doucette, Steve] Clin Res Ctr, Capital Hlth Res Serv, Dalhousie Dept Community Hlth & Epidemiol, Halifax, NS, Canada.
   [Kirk, Sara] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS B3H 4R2, Canada.
C3 Dalhousie University; Dalhousie University; Dalhousie University Hospital; Dalhousie University
RP Jurgens, TM (corresponding author), Dalhousie Univ, Coll Pharm, 5968 Coll St, Halifax, NS B3H 4R2, Canada.
EM tannis.jurgens@dal.ca
FU Nova Scotia Health Research Foundation, Canada; Knowledge Transfer/Exchange Program
CR Unknown -, 2008, JPN PHARMACOL THER, V0, P0
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bakker GCM, 2010, AM J CLIN NUTR, V91, P1044, DOI 10.3945/ajcn.2009.28822
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bayés M, 2005, METHOD FIND EXP CLIN, V27, P411
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bolling BW, 2009, CURR OPIN CLIN NUTR, V12, P42, DOI 10.1097/MCO.0b013e32831b9c48
   Boon N, 2008, INT J VITAM NUTR RES, V78, P275, DOI 10.1024/0300-9831.78.6.275
   Boschmann M, 2007, J AM COLL NUTR, V26, P389S, DOI 10.1080/07315724.2007.10719627
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Busse W, 2000, DRUG INF J, V34, P15, DOI 10.1177/009286150003400102
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Chacko Sabu M, 2010, CHIN MED, V5, P13, DOI 10.1186/1749-8546-5-13
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Clement Y, 2009, PREV MED, V49, P83, DOI 10.1016/j.ypmed.2009.05.005
   Dalbo VJ, 2008, J INT SOC SPORT NUTR, V5, P0, DOI 10.1186/1550-2783-5-6
   Di Pierro F, 2009, ALTERN MED REV, V14, P154
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eckel RH, 2008, NEW ENGL J MED, V358, P1941, DOI 10.1056/NEJMcp0801652
   Eichenberger P, 2009, INT J VITAM NUTR RES, V79, P24, DOI 10.1024/0300-9831.79.1.24
   Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Goto T, 1996, J CHROMATOGR A, V749, P295, DOI 10.1016/0021-9673(96)00456-6
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972
   Gupta J, 2008, IJP - INTERNATIONAL JOURNAL OF PHARMACOLOGY, V4, P314
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hill AM, 2007, J AM COLL NUTR, V26, P396S, DOI 10.1080/07315724.2007.10719628
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Jurgens T, 2009, BMC COMPLEM ALTERN M, V9, P0, DOI 10.1186/1472-6882-9-11
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Kataoka K, 2004, PROGRESS IN MEDICINE, V24, P3358
   Komatsu Tatsushi, 2003, JOURNAL OF MEDICAL INVESTIGATION, V50, P170
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kuhad A, 2008, DRUG FUTURE, V33, P249
   Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597
   Liberati A, 2009, ANN INTERN MED, V151, PW65, DOI 10.1371/journal.pmed.1000100
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Batista GDP, 2009, ARQ BRAS CARDIOL, V93, P121
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rao AV, 2006, JOURNAL OF HERBS, V0, P0
   Reinbach HC, 2009, CLIN NUTR, V28, P260, DOI 10.1016/j.clnu.2009.01.010
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Schneider C, 2009, AM FAM PHYSICIAN, V79, P591
   Seeram NP, 2006, J AGR FOOD CHEM, V54, P1599, DOI 10.1021/jf052857r
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   Sterne JA, 2001, SYSTEMATIC REVIEWS IN HEALTH CARE, V0, PP189, DOI 10.1002/9780470693926.ch11
   Sterne JAC, 2011, BMJ-BRIT MED J, V343, P0, DOI 10.1136/bmj.d4002
   Suzuki Y, 2009, JAPANESE PHARMACOLOGY AND THERAPEUTICS, V37, P521
   Takashima S, 2004, PROGRESS IN MEDICINE, V24, P3371
   Takeshita M, 2008, JPN PHARMACOL THER, V36, P767
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   Tian WX, 2004, LIFE SCI, V74, P2389, DOI 10.1016/j.lfs.2003.09.064
   Tsai CH, 2009, INT J FOOD SCI NUTR, V60, P151, DOI 10.1080/09637480903136667
   tsuchida t, 2002, PROG MED, V9, P2189
   Tucker LA, 2008, AM J HEALTH PROMOT, V23, P121, DOI 10.4278/ajhp.07051646
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wolfram S, 2007, J AM COLL NUTR, V26, P373S, DOI 10.1080/07315724.2007.10719626
   Yoneda T, 2009, METAB SYNDR RELAT D, V7, P349, DOI 10.1089/met.2008.0061
NR 100
TC 88
Z9 98
U1 1
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PD JUN 15
PY 2012
VL 0
IS 12
BP 
EP 
DI 10.1002/14651858.CD008650.pub2
PG 139
WC Medicine, General & Internal
SC General & Internal Medicine
GA 053EV
UT WOS:000312254600025
PM 23235664
DA 2025-04-28
ER

PT J
AU Greenberg, JA
   Geliebter, A
AF Greenberg, James A.
   Geliebter, Allan
TI Coffee, Hunger, and Peptide YY
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE coffee; decaffeinated coffee; caffeine; appetite; hunger; peptide YY; obesity; satiety hormones
ID food-intake; hormone-secretion; chlorogenic acid; long-term; obesity; weight; overweight; caffeine; volunteers; pyy3-36
AB Objective: There is evidence from several empirical studies suggesting that coffee may help people control body weight. Our objective was to assess the effects of caffeine, caffeinated coffee, and decaffeinated coffee, both alone and in combination with 75 g of glucose, on perceived hunger and satiety and related peptides. Methods: We conducted a placebo-controlled single-blinded randomized 4-way crossover trial. Eleven healthy male volunteers (mean age, 23.5 +/- 5.7 years; mean BMI, 23.6 +/- 4.2 kg/m(2)) ingested 1 of 3 test beverages (caffeine in water, caffeinated coffee, or decaffeinated coffee) or placebo (water), and 60 minutes later they ingested the glucose. Eight times during each laboratory visit, hunger and satiety were assessed by visual analog scales, and blood samples were drawn to measure 3 endogenous peptides associated with hunger and satiety: ghrelin, peptide YY (PYY), and leptin. Results: Compared to placebo, decaffeinated coffee yielded significantly lower hunger during the whole 180-minute study period and higher plasma PYY for the first 90 minutes (p < 0.05). Caffeine in water had no effects on hunger or PYY. Caffeinated coffee showed a pattern between that of decaffeinated coffee and caffeine in water. These findings suggest that one or more noncaffeine ingredients in coffee may have the potential to decrease body weight. Glucose ingestion did not change the effects of the beverages. Conclusions: Our randomized human trial showed that decaffeinated coffee can acutely decrease hunger and increase the satiety hormone PYY.
C1 [Greenberg, James A.] CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, Brooklyn, NY 11210 USA.
   [Geliebter, Allan] Columbia Univ, Dept Psychol, New York, NY 10027 USA.
   [Geliebter, Allan] St Lukes Roosevelt Hosp, New York Obes Nutr Res Ctr, New York, NY USA.
C3 City University of New York (CUNY) System; Brooklyn College (CUNY); Columbia University; Mount Sinai West; Mount Sinai St. Luke's
RP Greenberg, JA (corresponding author), CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, 2900 Bedford Ave, Brooklyn, NY 11210 USA.
EM jamesg@brooklyn.cuny.edu
FU Professional Staff Congress - City University of New York (PSC-CUNY) Research Award Program [68431-00 37]
CR Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887
   Bloom SR, 2008, MOL INTERV, V8, P82, DOI 10.1124/mi.8.2.6
   Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2
   Bult MJF, 2008, EUR J ENDOCRINOL, V158, P135, DOI 10.1530/EJE-07-0145
   Chaudhri OB, 2008, ANNU REV PHYSIOL, V70, P239, DOI 10.1146/annurev.physiol.70.113006.100506
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Dellalibera O, 2006, PHYTOTHERAPIE (PARIS), V4, P194, DOI 10.1007/s10298-006-0181-7
   DOUGLAS BR, 1990, AM J CLIN NUTR, V52, P553, DOI 10.1093/ajcn/52.3.553
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266
   Koegler FH, 2005, DIABETES, V54, P3198, DOI 10.2337/diabetes.54.11.3198
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lundsberg LS, 1998, CAFFEINE, V0, P199
   Moran TH, 2009, INT J OBESITY, V33, PS7, DOI 10.1038/ijo.2009.9
   (NHLBI) National Heart Lung and Blood Institute, 1998, NIH PUBL, V0, P0
   Onakpoya I, 2001, GASTROENT RES PRACT, V2011, P1
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Sileno AP, 2006, INT J OBESITY, V30, P68, DOI 10.1038/sj.ijo.0803067
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Ueno H, 2008, REGUL PEPTIDES, V145, P12, DOI 10.1016/j.regpep.2007.09.011
   Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325
NR 27
TC 23
Z9 30
U1 0
U2 34
PU AMER COLLEGE NUTRITION
PI CLEARWATER
PA 300 SOUTH DUNCAN AVENUE, STE 225, CLEARWATER, FL 33755 USA
SN 0731-5724
EI 
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD JUN 15
PY 2012
VL 31
IS 3
BP 160
EP 166
DI 10.1080/07315724.2012.10720023
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 069XN
UT WOS:000313470500004
PM 23204152
DA 2025-04-28
ER

PT J
AU Panchal, SK
   Wong, WY
   Kauter, K
   Ward, LC
   Brown, L
AF Panchal, Sunil K.
   Wong, Weng-Yew
   Kauter, Kate
   Ward, Leigh C.
   Brown, Lindsay
TI Caffeine attenuates metabolic syndrome in diet-induced obese rats
SO NUTRITION
LA English
DT Article
DE Obesity; Cardiovascular remodeling; Metabolic syndrome; Dyslipidemia; Adenosine receptor
ID adenosine receptors; insulin-resistance; fat; consumption
AB Objective: Caffeine is a constituent of many non-alcoholic beverages. Pharmacological actions of caffeine include the antagonism of adenosine receptors and the inhibition of phosphodiesterase activity. The A(1) adenosine receptors present on adipocytes are involved in the control of fatty acid uptake and lipolysis. In this study, the effects of caffeine were characterized in a diet-induced metabolic syndrome in rats. Methods: Rats were given a high-carbohydrate, high-fat diet (mainly containing fructose and beef tallow) for 16 wk. The control rats were given a corn starch diet. Treatment groups were given caffeine 0.5 g/kg of food for the last 8 wk of the 16-wk protocol. The structure and function of the heart and the liver were investigated in addition to the metabolic parameters including the plasma lipid components. Results: The high-carbohydrate, high-fat diet induced symptoms of metabolic syndrome, including obesity, dyslipidemia, impaired glucose tolerance, decreased insulin sensitivity, and increased systolic blood pressure, associated with the development of cardiovascular remodeling and nonalcoholic steatohepatitis. The treatment with caffeine in the rats fed the high-carbohydrate, high-fat diet decreased body fat and systolic blood pressure, improved glucose tolerance and insulin sensitivity, and attenuated cardiovascular and hepatic abnormalities, although the plasma lipid concentrations were further increased. Conclusion: Decreased total body fat, concurrent with increased plasma lipid concentrations, reflects the lipolytic effects of caffeine in adipocytes, likely owing to the caffeine antagonism of A1 adenosine receptors on ad ipocytes. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Panchal, Sunil K.; Kauter, Kate; Brown, Lindsay] Univ So Queensland, Dept Biol & Phys Sci, Toowoomba, Qld 4350, Australia.
   [Wong, Weng-Yew; Brown, Lindsay] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.
   [Ward, Leigh C.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.
C3 University of Southern Queensland; University of Queensland; University of Queensland
RP Brown, L (corresponding author), Univ So Queensland, Dept Biol & Phys Sci, Toowoomba, Qld 4350, Australia.
EM Lindsay.Brown@usq.edu.au
CR AMMON HPT, 1991, ARCH PHARM, V324, P261, DOI 10.1002/ardp.19913240502
   Arnaud Maurice J, 2011, HANDB EXP PHARMACOL, V0, PP33, DOI 10.1007/978-3-642-13443-2_3
   Bachmann K, 1996, ENVIRON HEALTH PERSP, V104, P400, DOI 10.2307/3432684
   Bhattacharya J, 2011, J ECON PERSPECT, V25, P139, DOI 10.1257/jep.25.1.139
   Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, PE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812
   Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P816, DOI 10.1002/art.22762
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Elzein E, 2008, EXPERT OPIN INV DRUG, V17, P1901, DOI 10.1517/13543780802497284
   Funakoshi H, 2006, CIRCULATION, V114, P2240, DOI 10.1161/CIRCULATIONAHA.106.620211
   Gao ZG, 2007, EXPERT OPIN EMERG DR, V12, P479, DOI 10.1517/14728214.12.3.479
   Gharibi B, 2012, INT J OBESITY, V36, P397, DOI 10.1038/ijo.2011.129
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Handa P, 2011, ARTERIOSCL THROM VAS, V31, P2827, DOI 10.1161/ATVBAHA.111.236554
   Heckman MA, 2010, J FOOD SCI, V75, PR77, DOI 10.1111/j.1750-3841.2010.01561.x
   HOLTZMAN SG, 1991, J PHARMACOL EXP THER, V256, P62
   Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180
   Jacobson Kenneth A, 2009, HANDB EXP PHARMACOL, V0, PP1, DOI 10.1007/978-3-540-89615-9_1
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   JORDA A, 1989, BIOCHEM PHARMACOL, V38, P2727, DOI 10.1016/0006-2952(89)90560-1
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Koren G, 2000, CAN FAM PHYSICIAN, V46, P801
   Liang HX, 2002, BRIT J PHARMACOL, V135, P1457, DOI 10.1038/sj.bjp.0704586
   McIntosh VJ, 2012, J CARDIOVASC PHARM T, V17, P21, DOI 10.1177/1074248410396877
   Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI 10.1097/FJC.0b013e3181feb90a
   Peng ZS, 2009, J CLIN INVEST, V119, P1052, DOI 10.1172/JCI37409C1
   Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Ribeiro JA, 2010, J ALZHEIMERS DIS, V20, PS3, DOI 10.3233/JAD-2010-1379
   Schäfer A, 2008, BRIT J PHARMACOL, V153, P886, DOI 10.1038/sj.bjp.0707459
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   SNYDER SH, 1984, J PSYCHIAT RES, V18, P91, DOI 10.1016/0022-3956(84)90001-3
   Szkudelski T, 2009, PHYSIOL RES, V58, P863, DOI 10.33549/physiolres.931467
NR 36
TC 65
Z9 69
U1 0
U2 31
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD OCT 15
PY 2012
VL 28
IS 10
BP 1055
EP 1062
DI 10.1016/j.nut.2012.02.013
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 013QJ
UT WOS:000309319600018
PM 22721876
DA 2025-04-28
ER

PT J
AU Wedick, NM
   Mantzoros, CS
   Ding, EL
   Brennan, AM
   Rosner, B
   Rimm, EB
   Hu, FB
   van Dam, RM
AF Wedick, Nicole M.
   Mantzoros, Christos S.
   Ding, Eric L.
   Brennan, Aoife M.
   Rosner, Bernard
   Rimm, Eric B.
   Hu, Frank B.
   van Dam, Rob M.
TI The effects of caffeinated and decaffeinated coffee on sex hormone-binding globulin and endogenous sex hormone levels: a randomized controlled trial
SO NUTRITION JOURNAL
LA English
DT Article
DE Coffee; Sex hormones; Randomized trial
ID postmenopausal women; risk; premenopausal; consumption; estradiol; alcohol; men
AB Background: Findings from observational studies suggest that sex hormone-binding globulin (SHBG) and endogenous sex hormones may be mediators of the putative relation between coffee consumption and lower risk of type 2 diabetes. The objective of this study was to evaluate the effects of caffeinated and decaffeinated coffee on SHBG and sex hormone levels. Findings: After a two-week run-in phase with caffeine abstention, we conducted an 8-week parallel-arm randomized controlled trial. Healthy adults (n = 42) were recruited from the Boston community who were regular coffee consumers, nonsmokers, and overweight. Participants were randomized to five 6-ounce cups of caffeinated or decaffeinated instant coffee or water (control group) per day consumed with each meal, mid-morning, and mid-afternoon. The main outcome measures were SHBG and sex hormones [i.e., testosterone, estradiol, dehydroepiandrosterone sulfate]. No significant differences were found between treatment groups for any of the studied outcomes at week 8. At 4 weeks, decaffeinated coffee was associated with a borderline significant increase in SHBG in women, but not in men. At week 4, we also observed several differences in hormone concentrations between the treatment groups. Among men, consumption of caffeinated coffee increased total testosterone and decreased total and free estradiol. Among women, decaffeinated coffee decreased total and free testosterone and caffeinated coffee decreased total testosterone. Conclusions: Our data do not indicate a consistent effect of caffeinated coffee consumption on SHBG in men or women, however results should be interpreted with caution given the small sample size. This is the first randomized trial investigating the effects of caffeinated and decaffeinated coffee on SHBG and sex hormones and our findings necessitate further examination in a larger intervention trial.
C1 [Wedick, Nicole M.; Ding, Eric L.; Rimm, Eric B.; Hu, Frank B.; van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Mantzoros, Christos S.] Harvard Univ, Sch Med, Boston VA Healthcare Syst, Endocrinol Sect, Boston, MA 02115 USA.
   [Mantzoros, Christos S.; Brennan, Aoife M.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA.
   [Ding, Eric L.; Rosner, Bernard; Rimm, Eric B.; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA.
   [Rosner, Bernard] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   [Rimm, Eric B.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [van Dam, Rob M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.
   [van Dam, Rob M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University Medical Affiliates; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University Medical Affiliates; Beth Israel Deaconess Medical Center; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National University of Singapore; National University of Singapore
RP Wedick, NM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.
EM nwedick@hsph.harvard.edu
FU Harvard Catalyst Human Research Center Laboratory Support Award; Boston Obesity Nutrition Research Center pilot and feasibility grant [2005-P-000377/2]; National Institutes of Health - National Center for Research Resources [M01-RR-01032]; National Institute of Diabetes and Digestive and Kidney Diseases [58785, 79929, 81913, AG032030];  [UL1 RR025758]
CR COOPER C, 1992, J BONE MINER RES, V7, P465
   Ding EL, 2007, DIABETOLOGIA, V50, P2076, DOI 10.1007/s00125-007-0785-y
   Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288
   Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381
   Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975
   Goto A, 2011, DIABETES, V60, P269, DOI 10.2337/db10-1193
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   LONDON S, 1991, AM J CLIN NUTR, V53, P166, DOI 10.1093/ajcn/53.1.166
   Lucero J, 2001, FERTIL STERIL, V76, P723, DOI 10.1016/S0015-0282(01)02005-2
   Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635
   PHILLIPS GB, 1992, STEROIDS, V57, P135, DOI 10.1016/0039-128X(92)90071-G
   SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
NR 13
TC 39
Z9 41
U1 1
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2891
EI 
J9 NUTR J
JI Nutr. J.
PD OCT 19
PY 2012
VL 11
IS 
BP 
EP 
DI 10.1186/1475-2891-11-86
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 041VF
UT WOS:000311428600001
PM 23078574
DA 2025-04-28
ER

PT J
AU Yuda, N
   Tanaka, M
   Suzuki, M
   Asano, Y
   Ochi, H
   Iwatsuki, K
AF Yuda, Naoki
   Tanaka, Miyuki
   Suzuki, Manabu
   Asano, Yuzo
   Ochi, Hiroshi
   Iwatsuki, Keiji
TI Polyphenols Extracted from Black Tea (Camellia sinensis) Residue by Hot-Compressed Water and Their Inhibitory Effect on Pancreatic Lipase in vitro
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE black tea; high-performance liquid chromatography-mass spectrometry; hot-compressed water; pancreatic lipase; residue; theaflavin
ID products; weight; wastes; green; fat
AB Polyphenols, retained in black tea wastes following the commercial production of tea beverages, represent an underutilized resource. The purpose of this study was to investigate the potential use of hot-compressed water (HCW) for the extraction of pancreatic lipase-inhibiting polyphenols from black tea residues. Black tea residues were treated with HCW at 10 degrees C intervals, from 100 to 200 degrees C. The resulting extracts were analyzed using high-performance liquid chromatography-mass spectrometry and assayed to determine their inhibitory effect on pancreatic lipase activity in vitro. Four theaflavins (TF), 5 catechins, 2 quercetin glycosides, quinic acid, gallic acid, and caffeine were identified. The total polyphenol content of extracts increased with increasing temperature but lipase inhibitors (TF, theaflavin 3-O-gallate, theaflavin 3'-O-gallate, theaflavin 3,3'-O-gallate, epigallocatechin gallate, and epicatechin gallate) decreased over 150 degrees C. All extracts inhibited pancreatic lipase but extracts obtained at 100 to 140 degrees C showed the greatest lipase inhibition (IC(50)s of 0.9 to 1.3 mu g/mL), consistent with the optimal extraction of TFs and catechins except catechin by HCW between 130 and 150 degrees C. HCW can be used to extract pancreatic lipase-inhibiting polyphenols from black tea waste. These extracts have potential uses, as dietary supplements and medications, for the prevention and treatment of obesity.
C1 [Yuda, Naoki; Tanaka, Miyuki; Suzuki, Manabu; Asano, Yuzo; Ochi, Hiroshi; Iwatsuki, Keiji] Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, Zama, Kanagawa 2528583, Japan.
C3 Morinaga Milk Industry Company, Ltd
RP Yuda, N (corresponding author), Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, 1-83,5 Chome, Zama, Kanagawa 2528583, Japan.
EM n-yuda@morinagamilk.co.jp
CR Arvanitoyannis IS, 2008, CRIT REV FOOD SCI, V48, P205, DOI 10.1080/10408390701279798
   Baysal T, 2000, J AGR FOOD CHEM, V48, P5507, DOI 10.1021/jf000311t
   Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848
   Drynan JW, 2010, NAT PROD REP, V27, P417, DOI 10.1039/b912523j
   Duran C, 2011, ANAL CHIM ACTA, V688, P75, DOI 10.1016/j.aca.2010.12.029
   Etoh H, 2010, BIOSCI BIOTECH BIOCH, V74, P858, DOI 10.1271/bbb.90800
   Farhoosh R, 2007, FOOD CHEM, V100, P231, DOI 10.1016/j.foodchem.2005.09.046
   Folin O, 1915, J BIOL CHEM, V22, P305
   Gu YY, 2011, J AGR FOOD CHEM, V59, P5305, DOI 10.1021/jf200180n
   Herrero M, 2006, FOOD CHEM, V98, P136, DOI 10.1016/j.foodchem.2005.05.058
   Hill JO, 1999, AM J CLIN NUTR, V69, P1108
   Jin FM, 2001, J SUPERCRIT FLUID, V19, P251, DOI 10.1016/S0896-8446(00)00094-2
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kante K, 2012, J HAZARD MATER, V201, P141, DOI 10.1016/j.jhazmat.2011.11.053
   Kurihara H, 2003, BIOL PHARM BULL, V26, P383, DOI 10.1248/bpb.26.383
   Kusano R, 2008, CHEM PHARM BULL, V56, P266, DOI 10.1248/cpb.56.266
   LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2
   MARSHALL WL, 1981, J PHYS CHEM REF DATA, V10, P295, DOI 10.1063/1.555643
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Sharma V, 2009, CRIT REV FOOD SCI, V49, P379, DOI 10.1080/10408390802068066
   Tsubaki S, 2008, J AGR FOOD CHEM, V56, P11293, DOI 10.1021/jf802253s
   van der Burg-Koorevaar MCD, 2011, J AGR FOOD CHEM, V59, P7752, DOI 10.1021/jf2015232
   Wiboonsirikul J, 2008, FOOD SCI TECHNOL RES, V14, P319, DOI 10.3136/fstr.14.319
NR 23
TC 64
Z9 68
U1 2
U2 100
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 
J9 J FOOD SCI
JI J. Food Sci.
PD DEC 15
PY 2012
VL 77
IS 12
BP H254
EP H261
DI 10.1111/j.1750-3841.2012.02967.x
PG 8
WC Food Science & Technology
SC Food Science & Technology
GA 057HK
UT WOS:000312553600009
PM 23106349
DA 2025-04-28
ER

